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Transcriptional control of gene expression is essential for life, tailoring protein production to 
development and environment to maintain organismal homeostasis. A limited set of proteins 
termed transcription factors are critical to this process. As our understanding of these central 
regulators has improved, new aspects of cell and organismal biology have been revealed. Herein, 
we demonstrate the importance of the transcription factor Bhlhe40 to tissue-resident 
macrophages, T helper type 2 cells, and type 2 immune responses, revealing novel transcriptional 
control of macrophages and unexpected cytokine regulation of helminth infection. We find that 
Bhlhe40 is cell-intrinsically required for normal proliferation of large serous cavity 
macrophages, but not other tissue-resident macrophage populations, revealing tissue-specific 
control of macrophage cycling active in homeostasis and type 2 immunity. Furthermore, we 
demonstrate that Bhlhe40 is critical for a normal transcription response of T helper cells to 
secondary infection with the helminth Heligmosomoides polygyrus bakeri (H. polygyrus). T cell-
intrinsic loss of Bhlhe40 impairs protective memory to H. polygyrus and reveals novel 
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Chapter 1: Introduction  
1.1 Transcription factors 
Transcriptional control is central to the structure and function of all life. Within the mammalian 
hematopoietic system, many transcription factors play indispensable roles in leukocyte lineages, 
including T-bet (T helper type 1 cells [TH1]) (Szabo et al., 2000), Gata binding protein 3 (Gata3, 
TH2 and type 2 innate lymphoid cells) (Zheng et al., 1997; Hoyler et al., 2012), retinoic acid 
receptor-related orphan receptor γt (RORγt, TH17 cells) (Ivanov et al., 2006)), Forkhead box P3 
(FoxP3, regulatory T cells) (Fontenot et al., 2003; Hori et al., 2003; Khattri et al., 2003), Basic 
leucine zipper transcriptional factor ATF-like 3 (Batf3, CD8+ dendritic cells) (Hildner et al., 
2008), PU.1 (macrophages and effects on other hematopoietic lineages) (Zhang et al., 1994), 
SpiC (red pulp macrophages) (Kohyama et al., 2009), Gata6 (large peritoneal macrophages 
[LPMs]) (Rosas et al., 2014; Gautier et al., 2014; Okabe and Medzhitov, 2014), Nuclear receptor 
subfamily 4 group A member 1 (Nr4a1, patrolling monocytes and thymic macrophages) (Hanna 
et al., 2011; Tacke et al., 2015), peroxisome proliferator-activated receptor γ (PPARγ, alveolar 
macrophages [AMs]) (Schneider et al., 2014), interferon response factor 4 (IRF4, small 
peritoneal macrophages [SPMs], CD4+ dendritic cells) (Kim et al., 2016; Tamura et al., 2005), 
IRF8 (CD8+ dendritic cells) (Tamura et al., 2005), liver X receptor α (LXRα, marginal zone 
macrophages) (A-Gonzalez et al., 2013), ThPOK (CD4+ T cells) (He et al., 2005; Sun et al., 
2005), Runt-related transcription factors (Runx, CD8+ T cells) (Woolf et al., 2003; Setoguchi et 
al., 2008), Myb (hematopoietic stem cells) (Schulz et al., 2012), and many others. Transcription 
factors control every aspect of a cell’s biology and are regulated by environmental factors and 
cell-intrinsic cues to enforce proper genetic programs for each given cell type. To achieve the 
great diversity of organ systems and cell types found in mammalian systems, transcription 
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factors are thought to function in a combinatorial fashion to create complex outcomes from a 
limited number of regulatory proteins (Glass and Natoli, 2016). Transcriptional regulators are 
also constrained by the accessibility of gene loci within the three-dimensional structure of 
chromatin, which is itself regulated by transcription factors that recruit histone-modifying 
enzymes to remodel chromatin accessibility in response to various stimuli (Glass and Natoli, 
2016). As a cell differentiates, transcription factors, in partnership with histone-modifying 
enzymes, begin to close chromatin, restricting possible gene expression. Chromatin accessibility 
is maintained or regained by the actions of pioneer transcription factors (or lineage-determining 
factors), which are often shared between closely related cell types (Glass and Natoli, 2016). The 
chromatin opened by pioneer transcription factors can then be accessed by signal-dependent 
transcription factors, creating the unique genetic program of each cell type (Glass and Natoli, 
2016). While pioneer transcription factors determine the general differentiation state of a cell 
(e.g. macrophage, T cell, B cell), signal-dependent factors impart unique characteristics to the 
same cell type within different environments (e.g. a naïve T cell in the brachial lymph node 
versus a resident memory T cell in the skin). While we have a robust understanding of many 
pioneer transcription factors, their diversity pales in comparison to that of signal-dependent 
factors, which are much less understood. Therefore, it is critical to achieve a better understanding 
of this class of transcriptional regulators.  
 
1.2 Bhlhe40 
We had previously performed a screen to identify transcription factors with intriguing expression 
patterns in myeloid cells, and this led us to an interesting candidate gene expressed in resident 
macrophages. When looking for transcription factors selectively induced in monocytes by the 
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cytokines macrophage colony stimulating factor (M-CSF, or CSF-1) or granulocyte-macrophage 
colony stimulating factor (GM-CSF, or CSF-2), we discovered that Basic helix-loop-helix, 
member e40 (Bhlhe40) was selectively induced by GM-CSF, but not M-CSF. Bhlhe40 is a 
transcriptional regulator that can both activate and repress gene targets and has been identified as 
a retinoic acid responsive gene by multiple groups (Boudjelal et al., 1997; Kato et al., 2014; Ow 
et al., 2014; Gosselin et al., 2014) as well as a regulator of the circadian clock (Honma et al., 2002). 
Bhlhe40 is further known to modulate the cell cycle, transcriptionally regulating cyclin D1 and 
exhibiting transcriptional control by p53 (Wang et al., 2012; Wang et al., 2015). Intriguingly, a 
recent study demonstrated that normal cycling of B1a cells is dependent on Bhlhe40 and the related 
transcription factor Bhlhe41 (with a primary dependence on Bhlhe41) (Kreslavsky et al., 2017). 
Taken together, these data connect Bhlhe40 to the cell cycle, but there is little evidence establishing 
a major role for this transcription factor in regulating the proliferation of hematopoietic cells. 
Within the immune system, Bhlhe40 is known to play an important role in various helper 
T cell subsets, including in TH1, TH17, and regulatory T cells (Yu et al., 2018; Lin et al., 2016; 
Miyazaki et al., 2010). While the related transcription factor Bhlhe41 has been shown to regulate 
TH2 cells (Yang et al., 2009; Liu et al., 2009), Bhlhe40 was not thought to regulate this population’s 
biology. However, a recent publication suggested that Bhlhe40 is a key regulator of in vitro-
polarized TH2 cells (Henriksson et al., 2019). We and others have previously shown that Bhlhe40 
is a critical regulator of T cell cytokine production in the multiple sclerosis model experimental 
autoimmune encephalomyelitis (Martinez-Llordella et al., 2013; Lin et al., 2014; Lin et al., 2016). 
Furthermore, we have described a key role for Bhlhe40 in myeloid cells and T cells in repressing 
interleukin-10 (IL-10) production to allow control of Mycobacterium tuberculosis (Huynh et al., 
2018), while another group has shown a similar role in T cells in protective immune responses 
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against Toxoplasma gondii (Yu et al., 2018). The best understood instance of cytokine regulation 
by Bhlhe40 is repression of the Il10 locus, which occurs via direct repression by Bhlhe40 and by 
Bhlhe40-mediated suppression of c-Maf, which itself supports IL-10 production (Huynh et al., 
2018; Yu et al., 2018; Gabrysova et al., 2018). Mechanistically, how Bhlhe40 antagonizes the Maf 
transcription factors is unclear. Taken together, these data collectively reveal important roles for 
Bhlhe40 in multiple T helper cell subsets, especially in the regulation of cytokine production, 
though it remains unclear whether Bhlhe40 regulates TH2 cells and type 2 immune responses. It is 
also uncertain whether Bhlhe40 regulates myeloid cells, despite marked expression in select 
macrophage populations (Lin et al., 2016). 
 
1.3 Type 2 immunity 
In contrast to many antiviral and antibacterial immune responses, the optimal type 2 response to 
helminths and allergens is often characterized by a state of tolerance, as these insults are generally 
present at delicate mucosal surfaces and in some cases are relatively innocuous. In the setting of 
many parasite infections, the sheer size of the organism renders phagocytosis an impossibility, 
requiring the secretion of anti-parasite effectors which are often stored in granules in eosinophils, 
basophils, and mast cells. These molecules, including histamine, leukotrienes, prostaglandins, and 
enzymes, are thought to either have directly toxic effects on parasites or to contribute to the so-
called “weep and sweep” response to expel worms by mucus production and intestinal contractility 
(Motran et al., 2018). Tissue-resident and/or monocyte-derived macrophages are also thought to 
play a key role in directly targeting parasites, likely through resistin-like proteins, chitinases, and 
arginase enzymatic activity (Anthony et al., 2006; Allen and Sutherland, 2014; Maizels et al., 
2018; Patel et al., 2009; Sorobetea et al., 2018). 
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Our understanding of the recruitment and activation of these effector populations has been 
significantly advanced by recent studies which have established an elegant system of cell-cell 
interactions and feedback loops prominently featuring innate lymphoid cells (ILCs) and epithelial 
tuft cells (Gerbe et al., 2016; Howitt et al., 2016; von Moltke et al., 2016). Activation of tuft cells 
increases their secretion of IL-25, which then acts on lymphocytes (initially type 2 ILCs (ILC2s)) 
to stimulate IL-13 production, which then acts back on epithelial progenitors to increase 
differentiation of tuft cells, thereby further enhancing IL-25 production and creating a positive 
feedback loop (Gerbe et al., 2016; Howitt et al., 2016; von Moltke et al., 2016). It is not yet entirely 
clear how this equation changes with the arrival of TH2 cells at the site of infection, but presumably 
these cells can replace or complement ILC2s in this circuit. While in some cases, helminths can 
be expelled without contributions from the adaptive immune system (Loser et al., 2019), in the 
majority of cases, TH2 cells will be recruited and a chronic infection will be established. In addition 
to production of IL-13, TH2 cells and/or ILC2s are stimulated to secrete other type 2 cytokines 
such as IL-5, which drives recruitment of eosinophils, and IL-4, which, along with IL-13, 
contributes to macrophage alternative activation (Patel et al., 2009; Jenkins et al., 2013; Allen and 
Sutherland, 2014; Maizels et al., 2018; Sorobetea et al., 2018). Key observations of the 
hyperproliferative behavior of macrophages during type 2 responses revolutionized our 
understanding of their biology and complemented a number of concurrent studies demonstrating 
that existing paradigms for their ontogeny were deeply flawed. 
 
1.4 Macrophages 
As a result of the work of many groups, we now understand that after conception, the yolk sac 
gives rise to the first wave of fetal macrophages, which colonize the developing embryo (Hoeffel 
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et al., 2015; Gomez-Perdiguero et al., 2015; Sheng et al., 2015). Later in development, these 
populations are largely replaced by a second wave of fetal liver-derived macrophages (Hoeffel et 
al., 2015; Gomez-Perdiguero et al., 2015; Sheng et al., 2015). Many of these embryonically-
derived macrophages persist into adulthood; however, different macrophage populations do 
exhibit varying degrees of replacement by adult bone marrow-derived monocytes (Hoeffel et al., 
2015; Gomez-Perdiguero et al., 2015; Sheng et al., 2015). Thus, throughout organismal life, 
macrophages colonize the body. In addition to phagocytosing dying cells during development 
and adult life (Cummings et al., 2016; A-Gonzalez et al., 2017), macrophages also possess a 
variety of tissue-specific accessory roles. 
A simplified initial view of macrophage biology, termed the M1/M2 paradigm, stipulated 
that macrophages polarized one of two ways, either into an M1 inflammatory phenotype 
(characterized by production of cytokines like tumor necrosis factor α and expression of inducible 
nitric oxide synthase) or an M2 anti-inflammatory, reparative state (characterized by induction of 
arginase and production of cytokines like IL-10) (Ginhoux et al., 2016). While of some utility, this 
view is now seen as an oversimplification. One positive effect of the M1/M2 paradigm is that it 
countered the traditional view that defined macrophages as pathogen-focused phagocytes, leading 
to a more nuanced view emphasizing their roles as tissue stromal cells adapted to their 
environment.  
Numerous examples of tissue-specific functions of macrophages have now been reported. 
AMs are required to handle surfactant and other material in the lung, as shown by the development 
of alveolar proteinosis in their absence (Shibata et al., 2001a; Shibata et al., 2001b; Schneider et 
al., 2014). Without red pulp macrophages of the spleen, clearance of red blood cells is impaired 
and an iron overload phenotype develops (Kohyama et al., 2009). Serous cavity macrophages have 
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been proposed to function as a reservoir of first responders to injuries of organs within these 
cavities or free bacteria (Wang et al., 2016; Zhang et al., 2019; Deniset et al., 2019). Splenic 
marginal zone macrophages are required for normal marginal zone development (A-Gonzalez et 
al., 2013). Furthermore, the field is just beginning to describe the signaling crosstalk connecting 
macrophages with non-hematopoietic cell types, for example with the nervous system in the gut 
or cardiomyocytes in the heart (Gabanyi et al., 2016; Hulsmans et al., 2017). Another example of 
such crosstalk is how adipose tissue macrophages can regulate thermogenesis (Nguyen et al., 
2011). It is perhaps unsurprising that cells of such a ubiquitous nature as macrophages possess 
other critical roles, especially in organisms which rarely confront pathogens within the solid organs 
of the body. Thus, tissue-resident macrophages spend the majority of their lifespan fulfilling 
homeostatic roles, rather than responding to pathogens. Therefore, the identity of macrophages 
within different tissues must considerably differ to fulfill these unique accessory functions. At the 
transcriptional level, resident macrophages possess significant diversity, exceeding that of 
dendritic cells within the same tissues (Gautier et al., 2012). This point is logical because all 
dendritic cells possess a common functional program of antigen acquisition within tissues followed 
by migration through a network of lymphatics to one of many highly related lymph nodes. This is 
in stark contrast to resident macrophages’ different functions within each tissue, which are thought 
to be supported by distinct gene expression patterns created by tissue-specific transcription factors. 
 
1.5 Transcriptional regulation of macrophages 
One mechanism which enforces tissue adaptation on macrophages is tissue-specific 
transcription factors. The first of these factors to be identified, Spi-C, was shown to be required 
for development of red pulp macrophages (Kohyama et al., 2009). Three groups independently 
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demonstrated that Gata6 was required for the generation of LPMs (Rosas et al., 2014; Gautier et 
al., 2014; Okabe and Medzhitov, 2014). Other studies showed key roles for peroxisome 
proliferator-activated receptor (PPAR) γ in AMs, NR4A1 in thymic macrophages, Id2 in 
Langerhans cells, IRF4 in SPMs, and liver x receptor α in splenic marginal zone macrophages 
(Scheider et al., 2014; Tacke et al., 2015; Chopin et al., 2013; Hacker et al., 2003; Kim et al., 2016; 
A-Gonzalez et al., 2014). Additionally, C/EBPβ is required for normal populations of LPMs, 
SPMs, and AMs (Cain et al., 2013). The transcription factor Zeb2 was recently shown to act 
broadly to help maintain tissue-resident macrophage identity (Scott et al., 2018). Thus, the 
regulation of resident macrophages is complex, employing a combination of specific or shared 
transcriptional regulators that may also play a key role in monocytes, dendritic cells, or other 
macrophage populations (e.g. C/EBPβ, NR4A1, ID2, Zeb2) (Cain et al., 2013; Hanna et al., 2011; 
Hacker et al., 2003; Scott et al., 2018). While still controversial, there is also strong evidence that 
environment dominates over ontogeny in defining the transcriptional program of resident 
macrophages, though further epigenetic studies are needed (Gibbings et al., 2015; van de Laar et 
al, 2016). Taken together, it is apparent that our understanding of the specific transcriptional 
controls regulating resident macrophages and the stimuli which induce them remains limited. In 
light of this, it is perhaps unsurprising that attempts to use macrophages therapeutically remain far 
from the clinic, though a study correcting alveolar proteinosis by macrophage transplantation 
showed promise (Suzuki et al., 2014). Furthermore, much of the literature is founded on studies of 
in vitro-derived or cultured cells, such as bone marrow-derived macrophages. It is nearly 
impossible to develop a biologically relevant understanding of a cell like the macrophage in vitro 
because of the critical role of environment in enforcing cellular identity. To achieve an 
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understanding of macrophage biology and to develop therapeutic applications, it is critical to 
employ in vivo macrophage populations amenable to manipulation. 
A cell of historical importance, the LPM is one of the most accessible macrophage 
populations of mammals and is thus a useful experimental subject for the study of tissue-resident 
macrophages. From studies of macrophage epigenetics and transcriptional regulation heavily 
relying on LPMs, a paradigm has been proposed whereby PU.1, which is a pioneer transcription 
factor required for the macrophage developmental program, cooperates with lineage-determining 
transcription factors or tissue-specific signal-dependent to drive tissue-resident macrophage 
differentiation (Gosselin et al., 2014). This suggests a mechanism by which core macrophage 
genes driven by PU.1 could be activated in all macrophages, while still inducing subset specific 
gene expression. While as of yet there is little direct evidence of the biological importance of this 
unifying theory, this study also demonstrates the utility of LPMs as a model macrophage. 
The development of LPMs is already known to require the LPM-specific transcription 
factor Gata6 (Rosas et al., 2014; Gautier et al., 2014; Okabe and Medzhitov et al., 2014), which 
may be induced by omentum-derived retinoic acid (Okabe and Medzhitov, 2014). As Bhlhe40 is 
also induced by retinoic acid in some cell types, this suggests that it may be of functional 
importance in LPMs. Until recently, the origins and regulation of the other population of peritoneal 
macrophages, SPMs, were unknown (Ghosn et al., 2010). We now know that SPMs are constantly 
replaced by monocytes and depend on IRF4 (Kim et al., 2017). In contrast to the maintenance of 
SPMs by monocyte replacement, studies on large serous cavity macrophages have revealed the 
remarkable capacity of macrophages to proliferate in homeostasis and type 2 immunity (Jenkins 
et al., 2011). Even in more inflammatory settings, LPMs retain a remarkable ability to self-renew 
after an enormous reduction in number within the peritoneal cavity, possibly from a subset of 
10 
 
LPMs expressing low levels of the renewal negative regulators MafB and c-Maf (Davies et al., 
2011; Soucie et al., 2016). These findings helped to overturn aspects of “the mononuclear 
phagocyte system,” or the belief that resident macrophages were continuously connected to 
monocytes and bone marrow hematopoiesis by replacement (Hume, 2006). In many cases, we now 
know that self-renewal and population expansion are dependent on in situ proliferation of resident 
macrophages, which is remarkable in light of their terminally differentiated state. 
 
1.6 Cell cycling of hematopoietic cells 
The two most fundamental biological processes are proliferation and cell death. Proper 
regulation of these processes is essential to normal development, tissue repair, control of 
infection, and avoidance of cancer. Every organ system exists in a constant equilibrium between 
life and death, with stem cell populations giving rise to terminally differentiated cells with a 
finite lifespan. After exit from quiescence, or Gap 0, cells cycle through four phases, Gap 1 (G1), 
Synthesis (S), Gap 2 (G2), and Mitosis (M) (Vermeulen et al., 2003; Satyanarayana and Kaldis, 
2009). This process is tightly regulated by cyclins, cyclin-dependent kinases (CDKs), 
retinoblastoma (Rb), and other regulators, including tumor suppressors such as p53 and CDK 
inhibitors (i.e. p21, p27) (Vermeulen et al., 2003; Satyanarayana and Kaldis, 2009). Within G1, 
accumulation of D cyclins activates CDK4/6 to allow progression through the restriction point, 
or the point of irrevocable commitment to the cell cycle without further extrinsic factors 
(Vermeulen et al., 2003; Satyanarayana and Kaldis, 2009). CDK4/6 then activate transcription of 
E2F transcription factors and phosphorylates Rb, allowing E2Fs to activate cyclin E transcription 
(Vermeulen et al., 2003; Satyanarayana and Kaldis, 2009). Cyclin E accumulation then activates 
CDK2 to allow progression into S phase and genome replication (Vermeulen et al., 2003; 
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Satyanarayana and Kaldis, 2009). Cyclin A-activated CDK2 promotes progression through S 
phase, while accumulation of Cyclin B activates CDK1 to initiate mitosis (Vermeulen et al., 
2003; Satyanarayana and Kaldis, 2009). However, further work has demonstrated that surprising 
deviations from this schema do occur and that loss of regulators deemed to be essential for cell 
proliferation can result in surprisingly mild phenotypes predominantly affecting specific cell 
types, as for genetic deletion of cyclin D2 or cyclin D3, which respectively affect B and T cells 
among other cell types (Barriere et al., 2007; Satyanarayana and Kaldis, 2009). These data 
indicate that there is nuance to the regulation of the cell cycle between different cell types 
(Barriere et al., 2007; Satyanarayana and Kaldis, 2009). 
As for other organs, the hematopoietic system must maintain itself. However, this occurs 
in some unusual ways. One of the defining characteristics of adaptive immunity is clonal 
expansion, or the dramatic proliferative expansion of a rare antigen-specific lymphocyte clone in 
response to cognate antigen. In recent work, tissue-resident T cells have been shown to locally 
proliferate and to be competent to generate a tissue immune response independent of memory 
cells resident in the lymphoid system (Beura et al., 2018). While tissue macrophages were long 
thought to be constantly replaced by monocytes, recent work has clearly demonstrated that the 
majority of these populations self-maintain independent of the bone marrow (Hashimoto et al., 
2013; Yona et al., 2013). This is also true of mast cells (Gentek et al., 2018). Furthermore, during 
certain immune responses, resident macrophages are capable of remarkable local proliferation, 
greatly expanding the population without contribution from monocytes (Jenkins et al., 2011). 
Thus, as for other biological systems, proliferation is essential to hematopoietic lineages. But it 
now appears that for many hematopoietic lineages, terminally differentiated cells are 
(surprisingly) capable of proliferation. As we have learned more about the role of proliferation 
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within the hematopoietic compartment, it has become clear that we have a very limited 
understanding of this process in many cell types. It is now known that the transcription factors c-
Maf and MafB (multiple macrophage lineages); Bhlhe41 (B1a cells); and AP4 (T and B cells) 
are novel regulators of hematopoietic proliferation (Aziz et al., 2009; Soucie et al., 2016; 
Kreslavsky et al., 2018; Chou et al., 2014; Chou et al., 2016). However, this limited set of factors 
is likely only a tiny fraction of undiscovered regulatory proteins. A fascinating outstanding 
question is whether mechanisms that allow terminally differentiated hematopoietic cells to 
proliferate can be exploited to therapeutically stimulate stromal regeneration in injury and 
disease. 
 
1.7 Resident macrophage self-renewal and expansion 
Classically, tissue macrophages were considered to be constantly replaced by monocytes, as can 
occur during infection. In contrast to this, two seminal studies established the embryonic origin of 
tissue-resident macrophages by showing that microglia were derived from yolk sac macrophages 
and that development of many resident macrophage populations was independent of the 
transcription factor Myb, which is required for classical hematopoiesis (Ginhoux et al., 2010; 
Schulz et al., 2012). While both groups established that resident macrophage maintenance could 
occur independent of the adult bone marrow (Ginhoux et al., 2010; Schulz et al., 2012), the 
definitive proof that renewal in the steady state did occur independent of monocytes was provided 
several years later (Yona et al., 2013; Hashimoto et al, 2013). However, how resident macrophage 
self-renewal is regulated remains unclear. Recent studies have described the transcription factors 
Mafb and c-Maf (encoded by Mafb and Maf) as repressors of macrophage proliferation (including 
in LPMs), as well as the deacetylase Sirtuin1 as a positive regulator of proliferation (Aziz et al., 
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2009; Soucie et al., 2016, Imperatore et al., 2017). In contrast,  loss of Gata6 has been described 
to cause multinucleation of LPMs, but Gata6-deficient macrophages are strikingly different from 
normal LPMs, making it unclear whether this is indicative of a primary defect in proliferation 
(Rosas et al., 2014; Gautier et al., 2014; Okabe and Medzhitov, 2014). Therefore, whether there is 
a prominent role for tissue-specific regulators in this process is not well understood. 
In addition to their self-renewal ability, resident macrophages are also capable of dramatic 
expansion in situ independent of the bone marrow (Jenkins et al., 2011). This process can be driven 
by the classic type 2 cytokines IL-4 and -13, as well as other type 2 cytokines (Jenkins et al., 2011, 
Jenkins et al., 2013, Jackson-Jones et al., 2016). Infection by helminths and other parasites drives 
T cell-mediated expansion and polarization of resident macrophages, and these populations are 
known to help control infection, both by cell-intrinsic and cell-cell mechanisms (Huang et al., 
2014; Huang et al.; 2017, Minutti et al., 2017; Anthony et al., 2006; Satoh et al., 2010; Turner et 
al., 2018; Campbell et al., 2018). Until recently, such macrophage proliferation was assumed to be 
predominantly controlled by Janus kinase (JAK) and signal transducer and activation of 
transcription (STAT) transcription factors and to occur similarly in all macrophage lineages. 
However, a recent study has described lineage-specific regulation of macrophage alternative action 
and expansion by the secreted collagens surfactant protein A and C1q (Minutti et al., 2017). 
Furthermore, differences in alternative activation between monocyte-derived and resident 
macrophages also demonstrate that macrophage ontogeny can inform this process (Gundra et al., 
2014, Gundra et al., 2017). Whether there are common regulators of both macrophage self-renewal 




1.8 T cell responses in peripheral tissues 
As our understanding of the biology of macrophages has evolved, so has our view of the 
mechanisms by which T helper cells support macrophage responses. In contrast to the traditional 
view of recruited T cells driving recruitment of monocytes to form macrophages at the site of 
infection, we now know that both the relevant T cell and macrophage populations can be resident 
in the tissue and imprinted with unique transcriptional programs by tissue residency (Masopust et 
al., 2001; Ginhoux et al., 2010; Schulz et al., 2012; T’Jonck et al., 2018). While it was formerly 
thought that T cells simply polarized macrophages via cytokine secretion, it is now understood 
that T cell-derived cytokines also can control their proliferative behavior and release the usual 
restrictions imposed by the availability of M-CSF on a tissue’s carrying capacity (Jenkins et al., 
2011; Jenkins et al., 2013). Furthermore, while we are still at a very early stage, interactions 
between the tissue stroma and hematopoietic cells are beginning to be established, particularly in 
the case of epithelial and neural cells (Shibata et al., 2001a; Shibata et al., 2001b; Kohyama et 
al., 2009; Nguyen et al., 2011; A-Gonzalez et al., 2013; Schneider et al., 2014; Gabanyi et al., 
2016; Hulsmans et al., 2017; Panduro et al., 2018; Cohen et al., 2018). In the case of T cells, 
much of our current understanding of this process is centered around their remarkable capacity 
for cytokine secretion in an antigen-driven fashion. 
 
1.9 Regulation of TH2 cell cytokine production 
Much effort has been spent on establishing the transcriptional regulation of TH2 cells, including 
the transcription factors BATF (Bao et al., 2016), Bhlhe41 (Yang et al., 2009; Liu et al., 2009), 
c-Maf (Gabrysova et al., 2018), Gfi-1 (Zhu et al., 2002), IRF4 (Lohoff et al., 2002), NFIL3 
(Kashiwada et al., 2011), PPARγ (Nobs et al., 2017), TCF-1 (Yu et al., 2009), and YY1 (Hwang 
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et al., 2013), often with a particular emphasis on differentiation. However, a new paradigm is 
emerging that transcription factors (such as BATF, Bhlhe40, c-Maf, and NFIL3) can regulate T 
cell effector functions downstream of differentiation (Bao et al., 2016; Martinez-Llordella et al., 
2013; Lin et al., 2014; Lin et al., 2016; Huynh et al., 2018; Yu et al., 2018; Gabrysova et al., 
2018; Kashiwada et al., 2011). c-Maf and Bhlhe40 are the two best characterized examples of 
this and likely overlap at the level of regulation of IL-10 (Gabrysova and O’Garra., 2018; Huynh 
et al., 2018; Yu et al., 2018). Bhlhe40 is now known to regulate GM-CSF, IL-10, and interferon 
γ production, suggesting that it is a central regulator of T cell cytokine production (Martinez-
Llordella et al., 2013; Lin et al., 2014; Lin et al., 2016; Huynh et al., 2018; Yu et al., 2018). 
However, it is not clear whether Bhlhe40 regulates TH2 cell cytokine production. While 
unrelated to these studies, it is of great interest to further address the role of Bhlhe40 in 
regulating cytokine production in other hematopoietic lineages. There are some indications that 










Chapter 2: Bhlhe40 is a tissue-specific transcriptional 
regulator of the proliferation of peritoneal macrophages 
 
The contents of this chapter have been modified from the following published article: 
 
Bhlhe40 mediates tissue-specific control of macrophage proliferation in homeostasis and 
type 2 immunity 
 
NN Jarjour, EA Schwarzkopf, TR Bradstreet, I Shchukina, C-C Lin, SC-C Huang, C-W Lai, ME 
Cook, R Taneja, TS Stappenbeck, GJ Randolph, MN Artyomov, JF Urban, Jr., BT Edelson. 
Nature Immunology, 2019;20(6):687 
 
2.1 Abstract 
Most tissue-resident macrophage populations develop during embryogenesis, self-renew in the 
steady-state and expand during type 2 immunity. Whether shared mechanisms regulate the 
proliferation of macrophages in homeostasis and disease is unclear. Here we found that the 
transcription factor Bhlhe40 was required in a cell-intrinsic manner for the self-renewal and 
maintenance of large peritoneal macrophages (LPMs), but not that of other tissue-resident 
macrophages. Bhlhe40 was necessary for the proliferation, but not the polarization, of LPMs in 
response to the cytokine IL-4. During infection with the helminth Heligmosomoides polygyrus 
bakeri, Bhlhe40 was required for cell cycling of LPMs. Bhlhe40 repressed the expression of 
genes encoding the transcription factors c-Maf and Mafb and directly promoted expression of 
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transcripts encoding cell cycle-related proteins to enable the proliferation of LPMs. In LPMs, 
Bhlhe40 bound to genomic sites co-bound by the macrophage lineage-determining factor PU.1 
and to unique sites, including Maf and loci encoding cell cycle-related proteins. Our findings 
demonstrate a tissue-specific control mechanism that regulates the proliferation of resident 
macrophages in homeostasis and type 2 immunity. 
 
2.2 Introduction 
Tissue-resident macrophages are established during embryogenesis (Ginhoux et al., 2010; Schulz 
et al., 2012; T’Jonck et al., 2018) and are largely maintained by local self-renewal within each 
organ (Hashimoto et al., 2013; Yona et al., 2013). While some transcription factors specifying 
distinct macrophage lineages have been described (T’Jonck et al., 2018), differences in the 
transcriptional basis for self-renewal in distinct macrophage populations are not well understood. 
Established regulators of self-renewal in multiple macrophage lineages include the anti-
proliferative transcription factors c-Maf and MafB (Aziz et al., 2009; Soucie et al., 2016), as well 
as the pro-proliferative deacetylase Sirtuin1 (Imperatore et al., 2017). The transcription factor 
Gata6 may exercise tissue-specific control of macrophage self-renewal, as loss of Gata6 causes 
large peritoneal macrophages (LPMs) to become multinucleated and impairs their proliferation 
(Rosas et al., 2014). However, deletion of Gata6 also causes changes in the morphology, surface 
markers and gene expression profile of LPMs (Rosas et al., 2014; Gautier et al., 2014; Okabe and 
Medzhitov, 2014), illustrating that the study of tissue-specific control of resident macrophage 
self-renewal can be confounded by significant effects on macrophage identity. It remains unclear 
to what extent macrophage self-renewal is regulated in a tissue-specific manner and whether any 
tissue-specific regulation that does exist cooperates with broadly shared regulators. 
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 In addition to their homeostatic self-renewal capacity, resident macrophages can become 
alternatively activated in response to type 2 cytokines produced in response to stimuli like 
helminth infection, resulting in dramatic proliferation concomitant with acquisition of a pro-
repair or anti-helminth protein expression profile (Jenkins et al., 2011; Jenkins et al., 2013; 
Ruckerl and Allen, 2014; Minutti et al., 2017; Bosurgi et al., 2017). Until recently, proliferation 
of all macrophages elicited by type 2 immunity was assumed to be controlled by cytokine 
signaling through JAK kinases and STAT transcription factors. While it remains unclear whether 
tissue-specific, cell-intrinsic transcriptional regulation influences this process, the collagens SP-
A and C1q act through the receptor Myo18a to mediate extrinsic, tissue-specific regulation of 
proliferation and alternative activation (Minutti et al., 2017). Signaling through receptors for 
apoptotic cells also influences these processes in tissue-resident macrophages (Bosurgi et al., 
2017). Furthermore, differences in alternative activation between monocyte-derived and resident 
macrophages indicate that ontogeny influences responses during type 2 immunity (Gundra et al., 
2014; Gundra et al., 2017). Whether there are common regulators of macrophage self-renewal at 
steady-state and proliferation during disease remains unknown.  
 The transcription factor Bhlhe40 is expressed in some hematopoietic and non-
hematopoietic cell types (Kato et al., 2014; Ow et al., 2014), including select resident 
macrophage populations (Lin et al., 2016). Bhlhe40 binds to DNA at class B E-box motifs and 
functions primarily as a transcriptional repressor (Sun and Taneja, 2000; St.-Pierre et al., 2002; 
Park et al., 2012; Ow et al., 2014; Kato et al., 2014; Qian et al., 2014), although examples of 
transcriptional activation have been described (Li et al., 2006; Qian et al., 2014). Bhlhe40 is 
dysregulated in some cancers and may regulate cell cycling in specific contexts (Ow et al., 
2014). A variety of hematopoietic cell types are regulated by Bhlhe40, including NKT cells and 
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B cells (Seimiya et al., 2004; Kanda et al., 2016; Kreslavsky et al., 2017; Camponeschi et al., 
2018), and it controls cytokine production in T cells during infection and autoimmunity 
(Martinez-Llordella et al., 2013; Lin et al., 2014; Lin et al., 2016; Huynh et al., 2018; Yu et al., 
2018). Bhlhe40 and c-Maf may be interconnected in the regulation of the cytokine IL-10, but 
how this would occur is unclear (Yu et al., 2018; Gabrysova and O’Garra, 2018). Despite an 
emerging view that Bhlhe40 is an important regulator of immunity, little is known regarding its 
role in myeloid cells. Bhlhe40 has been proposed as a tissue-specific binding partner of PU.1 in 
LPMs, but this has not been directly tested (Gosselin et al., 2014). 
Here we found that Bhlhe40 had a unique and cell-intrinsic role in LPMs to regulate self-
renewal, proliferation and accumulation during type 2 immunity. In LPMs, Bhlhe40 bound a 
subset of genomic sites bound by the macrophage lineage-specifying transcription factor PU.1, 
but also many unique sites, including loci encoding cell cycle-related proteins such as c-Maf. 
Loss of Bhlhe40 in LPMs led to higher expression of Maf and Mafb mRNA and lower 
expression of cell cycle-related transcripts. Our findings establish Bhlhe40 as a tissue-specific 
transcriptional regulator of LPM proliferation active in both homeostatic self-renewal and upon 
rapid cell cycling during type 2 immunity. 
 
2.3 Results 
Loss of Bhlhe40 selectively reduces LPMs 
Because Bhlhe40 expression has been observed in select resident macrophage populations (Lin 
et al., 2016; Gautier et al., 2012; Lavin et al., 2014), we examined macrophages from mice 
transgenic for a Bhlhe40GFP bacterial artificial chromosome (Bhlhe40GFP+ mice hereafter) (Lin et 
al., 2016). We observed low or undetectable GFP expression in Ly6G-CD115+ Ly6Chi and 
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Ly6Clo blood monocytes, F4/80hi splenic red pulp macrophages (hereafter red pulp 
macrophages), CD45intCD11b+ central nervous system microglia, CD45+CD11bloF4/80hi liver 
Kupffer cells (hereafter Kupffer cells), CD45+Ly6C-CD11b+F4/80hi kidney macrophages 
(hereafter kidney macrophages) and CD45+Ly6C-F4/80+CD64+MHC-II+ small intestinal lamina 
propria macrophages (hereafter SI macrophages), but found high expression of GFP in 
CD45+Siglec-F+CD11c+ lung alveolar macrophages (hereafter AMs), 
CD115+CD11b+ICAM2+MHC-IIint large peritoneal macrophages (hereafter LPMs), 
CD115+CD11b+MHC-II+ICAM2- small peritoneal macrophages (hereafter SPMs), 
CD115+CD11b+ICAM2+MHC-IIint large pleural macrophages (hereafter large pleural 
macrophages) and CD115+CD11b+MHC-II+ICAM2- small pleural macrophages (hereafter small 
pleural macrophages) (Fig. 2.1A and Fig. 2.2A). Of the populations examined, only LPMs and 
SPMs were decreased in Bhlhe40-/- compared to Bhlhe40+/+ mice (Fig. 2.1B, C and Fig. 2.2B-
E). In some resident macrophage populations, including LPMs, Tim4 is a marker of 
embryonically-derived, long-lived resident macrophages (Scott et al., 2016; Bain et al., 2016; 
Shaw et al., 2018), while CD226 marks mature SPMs (Kim et al., 2016). Decreases in Tim4+ 
LPMs and CD226+ SPMs largely accounted for the reduced number of peritoneal macrophages 
in Bhlhe40-/- mice (Fig. 2.2F-I). The number of peritoneal CD115-MHC-II+CD19+ B cells 
(hereafter B cells) was not reduced in Bhlhe40-/- compared to Bhlhe40+/+ mice (Fig. 2.2J). 
Therefore, loss of Bhlhe40 selectively reduced the number of LPMs and SPMs. 
 
Bhlhe40 is required in LPMs for self-renewal 
To address whether the loss of LPMs in Bhlhe40-/- mice was due to impaired proliferation, we 
stained peritoneal cells from Bhlhe40+/+ and Bhlhe40-/- mice for Ki67, a marker of cycling cells. 
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We observed a 4-fold increase in the frequency of Ki67+ LPMs (Fig. 2.1D, E), but little change 
in the frequency of Ki67+ SPMs and peritoneal B cells in Bhlhe40-/- compared to Bhlhe40+/+ mice 
(Fig. 2.1E). Despite normal numbers, we found an increase in the frequency of Ki67+ large 
pleural macrophages in Bhlhe40-/- compared to Bhlhe40+/+ mice (Fig. 2.2K, L). There was no 
difference in the uptake of bromodeoxyuridine (BrdU), which is incorporated during the S phase, 
in LPMs from Bhlhe40+/+ and Bhlhe40-/- mice 3 hours after injection with BrdU (Fig. 2.1F, G). 
Staining for the mitosis marker phosphohistone H3 (pHH3) was similar in Bhlhe40+/+ and 
Bhlhe40-/- LPMs (Fig. 2.1H, I). When using Ki67 and the nuclear stain 4′,6-diamidino-2-
phenylindole (DAPI) to separate the phases of the cell cycle, we observed an increased number 
of LPMs in the G1 phase (Fig. 2.1J, K), but similar numbers of LPMs in the S, G2 and M phases 
in Bhlhe40-/- compared to Bhlhe40+/+ mice (Fig. 2.1J, K), suggesting that Bhlhe40-/- LPMs were 
impaired in progressing from G1, but proliferated sufficiently to maintain a stable, although 
reduced, population of LPMs. The proportion of LPMs staining for the viability dye 7-
aminoactinomycin D (7-AAD) was similar in Bhlhe40+/+ and Bhlhe40-/- mice (Fig. 2.2M). Taken 
together, these data indicate that Bhlhe40 was required for normal proliferation of LPMs. 
 
Bhlhe40 is required intrinsically in LPMs for cell cycling 
To address whether the role of Bhlhe40 in LPMs was cell-intrinsic, we generated mixed bone 
marrow chimeras by co-transfer of equal numbers of Bhlhe40+/+ (CD45.1) plus either Bhlhe40+/+ 
(CD45.2) or Bhlhe40-/- (CD45.2) total bone marrow cells into irradiated Bhlhe40+/+ 
CD45.1/CD45.2 mice, which were allowed to reconstitute for >8 weeks. Out of peritoneal, 
blood, splenic, liver, kidney, SI lamina propria, lung and pleural hematopoietic populations 
examined, only LPMs and large pleural macrophages exhibited Bhlhe40-dependent 
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reconstitution (Bhlhe40+/+ outnumbering Bhlhe40-/- cells by more than 10:1) (Fig. 2.3A-D and 
Fig. 2.4A and data not shown). The small number of Bhlhe40-/- LPMs in mixed chimeras 
accumulated in the G1 phase (Fig. 2.3E, F), indicating that the alterations in cell cycling in 
Bhlhe40-/- LPMs were cell-intrinsic. Next, we bred LysM-Cre+ Bhlhe40fl/fl mice to delete 
Bhlhe40 in myeloid cells. Compared to LysM-Cre- Bhlhe40fl/fl mice, LysM-Cre+ Bhlhe40fl/fl mice 
had a nearly 2-fold reduction in the number of LPMs, with no change in SPMs or peritoneal B 
cells (Fig. 2.3G) and an increased proportion of LPMs in the G1 phase (Fig. 2.3H, I). Finally, 
we co-transferred Bhlhe40+/+ (CD45.1) plus either Bhlhe40+/+ (CD45.2) or Bhlhe40-/- (CD45.2) 
bulk peritoneal cells into resting Bhlhe40+/+ (CD45.1/CD45.2) mice at ratios calculated to result 
in the transfer of equal numbers of LPMs (200,000-300,000) from each donor. Over four weeks, 
the relative proportion of transferred Bhlhe40+/+ (CD45.1) to Bhlhe40-/- (CD45.2) LPMs was 
increased (Fig. 2.3J, K and Fig. 2.4B), while the relative proportion of transferred Bhlhe40+/+ 
(CD45.1) to transferred Bhlhe40-/- (CD45.2) B cells was maintained in the peritoneum (Fig. 2.3J, 
L and Fig. 2.4B), supporting a cell-intrinsic role for Bhlhe40 in mature LPMs. Thus, Bhlhe40 
was cell-intrinsically required in LPMs for normal proliferation and maintenance. 
 
Loss of Bhlhe40 dysregulates a unique set of genes in LPMs 
Next, we performed gene expression microarrays to determine the transcriptional differences 
between LPMs from Bhlhe40+/+ and Bhlhe40-/- mice. 84 genes were dysregulated by 2-fold or 
more in Bhlhe40-/- compared to Bhlhe40+/+ LPMs (Fig. 2.5A), including expression changes in 
several genes related to macrophage alternative activation, such as Chil3, Clec10a, Mrc1 and 
Arg1 (Fig. 2.5B). We validated these data by flow cytometry for several proteins encoded by 
differentially expressed genes (Emb, Clec10a, Lyve1) (Fig. 2.5C-E). When we assessed the 
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expression of gene ontology sets (Subramanian et al., 2005) in the absence of Bhlhe40 using the 
list of genes that were differentially expressed ≥1.5-fold between Bhlhe40+/+ and Bhlhe40-/- 
LPMs, we found that the Regulation of cell proliferation gene set was enriched in Bhlhe40+/+ 
LPMs, while some immune response-related gene sets were enriched in Bhlhe40-/- LPMs (Fig. 
2.5F, G). We validated higher expression of Maf and Mafb mRNA in Bhlhe40-/- compared to 
Bhlhe40+/+ LPMs in our microarrays (data not shown) by qRT-PCR (Fig. 2.5H), consistent with 
impaired proliferation of Bhlhe40-/- LPMs.  
Because the transcription factor Gata6 is an important regulator of LPMs (Rosas et al., 
2014; Gautier et al., 2014; Okabe and Medzhitov, 2014), we reanalyzed our microarray data and 
published microarray data (Gautier et al., 2014) from LysM-Cre- Gata6fl/fl and LysM-Cre+ 
Gata6fl/fl LPMs to look for differentially expressed genes regulated by both transcription factors. 
Expression of Gata6 mRNA was not substantially changed in Bhlhe40-/- LPMs (log2 expression, 
Bhlhe40+/+ 10.24, Bhlhe40-/- 10.10; data not shown), nor did loss of Gata6 cause substantial 
changes in the expression of Bhlhe40 in LPMs (log2 expression, LysM-Cre
- Gata6fl/fl 10.04, 
LysM-Cre+ Gata6fl/fl 9.81; data not shown). Furthermore, the majority of Bhlhe40-dependent 
genes were not dependent on Gata6 and the converse was likewise true (Fig. 2.4C, D). 
Next, we performed transcriptome analysis of AMs, which have high expression of 
Bhlhe40, from Bhlhe40+/+ and Bhlhe40-/- mice. Compared to LPMs, Bhlhe40 controlled a largely 
distinct and smaller group of genes in AMs, mostly encoding proteins involved in antigen 
presentation by MHC class II (H2-Aa, H2-Ab1, H2-Eb1, Cd74; Fig. 2.5I). A set of genes 
selectively expressed in LPMs relative to AMs, splenic red pulp macrophages and microglia has 
been previously curated (Gautier et al., 2012). Bhlhe40 regulated the expression of only a small 
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subset of these genes (Lrg1, Stard13, Nedd4) (Fig. 2.4E). Therefore, Bhlhe40 regulated a cell 
type-specific set of genes in LPMs, but was dispensable for identity. 
 
Bhlhe40 is required for LPM responses during type 2 immunity 
We then asked whether Bhlhe40 was required for macrophage accumulation during peritoneal 
immune responses characterized either by the differentiation of monocyte-derived macrophages 
or the local proliferation of LPMs. Intraperitoneal (i.p.) injection of thioglycollate, which elicits 
the recruitment and differentiation of blood-derived monocytes to the peritoneum independent of 
proliferation (Gautier et al., 2013; Gundra et al., 2014), resulted in equivalent accumulation of 
CD115+CD11b+ICAM2lo thioglycollate-elicited macrophages (hereafter thioglycollate-elicited 
macrophages) in Bhlhe40+/+ and Bhlhe40-/- mice after 4 days (Fig. 2.6A, B), while the i.p 
injection of IL-4+anti-IL-4 antibody complexes (hereafter IL-4c), which elicit the robust 
proliferation of resident macrophages (Jenkins et al., 2011), caused a 5-fold increase in the 
number of LPMs in Bhlhe40+/+ mice compared to Bhlhe40-/- mice after 4 days (Fig. 2.6C, D). 
Similar findings were obtained in LysM-Cre- Bhlhe40fl/fl and LysM-Cre+ Bhlhe40fl/fl mice (Fig. 
2.6D), suggesting Bhlhe40 was required for the proliferation of resident LPMs in a cell-intrinsic 
manner. SPMs were not reduced in Bhlhe40-/- and LysM-Cre+ Bhlhe40fl/fl compared to Bhlhe40+/+ 
and LysM-Cre- Bhlhe40fl/fl mice in response to IL-4c (Fig. 2.6E). Because Bhlhe40 represses the 
production of IL-10 in T cells and myeloid cells (Lin et al., 2014; Lin et al., 2016; Huynh et al., 
2018; Yu et al., 2018), we injected IL-4c i.p. into Bhlhe40-/- Il10-/- mice to test whether lack of 
IL-10 restored the IL-4c-driven accumulation of LPMs in the absence of Bhlhe40. Similar to 
Bhlhe40-/- mice, Bhlhe40-/- Il10-/- mice had poor accumulation of LPMs after injection of IL-4c 
(Fig. 2.7A, B), indicating IL-10 did not contribute to the impaired response of Bhlhe40-/- LPMs. 
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Taken together, these data indicate that Bhlhe40 was required for normal accumulation of LPMs 
in response to IL-4c. 
 
Bhlhe40 regulates proliferation, but not polarization, of LPMs 
We next assessed whether Bhlhe40 regulated induction of the alternative activation markers 
RELMα and Clec10a in LPMs in response to IL-4c. LPMs from Bhlhe40+/+, Bhlhe40-/-, LysM-
Cre- Bhlhe40fl/fl and LysM-Cre+ Bhlhe40fl/fl mice all induced these proteins following i.p. 
injection with IL-4c (Fig. 2.8A, B). In contrast, IL-4c increased the proportions of BrdU+ LPMs 
and pHH3+ LPMs by approximately 2-fold in Bhlhe40+/+ and LysM-Cre- Bhlhe40fl/fl mice 
compared to Bhlhe40-/- and LysM-Cre+ Bhlhe40fl/fl mice (Fig. 2.8C, D). IL-4c treatment also 
elicited a greater increase in the fraction of LPMs in the G1, S and G2M phases of the cell cycle 
in Bhlhe40+/+ compared to Bhlhe40-/- mice (Fig. 2.8E). Immunoblot analysis of cyclins D1-D3, 
cyclin dependent kinase (CDK) 2, CDK4, CDK6 and the transcription factor E2F2, which 
regulate the G1 and S phases of the cell cycle (Bertoli et al., 2013), showed increases in cyclin 
D3, CDK2 and CDK4 in LPMs from IL-4c-treated compared to naïve mice (Fig. 2.7C); 
however, their abundance was generally similar in Bhlhe40+/+ and Bhlhe40-/- LPMs (Fig. 2.7C). 
In contrast to cyclins and CDKs, E2F2 was similar in LPMs from mice injected or not with IL-4c 
(Fig. 2.7C). 7-AAD+ necrotic LPMs were somewhat increased in IL-4c-injected Bhlhe40-/- and 
LysM-Cre+ Bhlhe40fl/fl mice compared to Bhlhe40+/+ and LysM-Cre- Bhlhe40fl/fl mice (Fig. 2.8F). 
In mixed bone marrow chimeras (generated and reconstituted as in Fig. 2.3A-F) injected i.p. 
with IL-4c, a lower proportion of Bhlhe40-/- LPMs incorporated BrdU compared to Bhlhe40+/+ 
LPMs within the same recipient (Fig. 2.7D). 
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We used transmission electron microscopy of bulk peritoneal cells from naïve and IL-4c-
treated Bhlhe40+/+ and Bhlhe40-/- mice to assess cell morphology. Bhlhe40+/+ and Bhlhe40-/- 
LPMs from IL-4c-treated mice showed increases in cell size and endoplasmic reticulum (ER) 
extent compared to naïve LPMs (Fig. 2.9). We observed no distinct morphology between naïve 
Bhlhe40-/- and Bhlhe40+/+ LPMs, while LPMs from IL-4c-treated Bhlhe40-/- mice were somewhat 
larger and more vacuolated than LPMs from IL-4c-treated Bhlhe40+/+ mice, without any severe 
morphologic defects (Fig. 2.9). Therefore, Bhlhe40 was required for LPMs to rapidly cycle in 
response to IL-4c, but was dispensable for normal morphology and induction of alternative 
activation markers. 
 
Monocytes can acquire a Bhlhe40-dependent proliferative program 
Next we asked whether Bhlhe40 was required for the IL-4c-induced proliferation of other 
macrophages. IL-4c injection i.p. into Bhlhe40GFP+ mice did not change the expression of GFP in 
LPMs, SPMs, AMs, kidney macrophages, red pulp macrophages and Kupffer cells compared to 
these populations in PBS-treated Bhlhe40GFP+ mice (Fig. 2.10A). IL-4c injection i.p. into 
Bhlhe40+/+ and Bhlhe40-/- mice resulted in equivalent BrdU incorporation by, and numbers of, 
red pulp macrophages, Kupffer cells and AMs (Fig. 2.8G and Fig. 2.10B-E), in contrast to 
LPMs and large pleural macrophages, which required Bhlhe40 for a normal population of BrdU-
incorporating cells in response to IL-4c (Fig. 2.8G).  
 Injection of thioglycollate and IL-4c i.p. causes monocyte-derived macrophages to 
proliferate and acquire alternative activation markers (Gundra et al., 2014; Gundra et al., 2017). 
When we asked whether Bhlhe40 was expressed in these monocyte-derived macrophages, we 
found that the combination of thioglycollate and IL-4c induced marked expression of GFP in the 
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thioglycollate-elicited macrophages in Bhlhe40GFP+ mice compared to a lower expression of GFP 
in macrophages elicited by thioglycollate alone (Fig. 2.8H). After treatment with thioglycollate 
and IL-4c, Bhlhe40-/- mice had severely reduced proportions of BrdU+ and pHH3+ thioglycollate-
elicited macrophages compared to Bhlhe40+/+ mice (Fig. 2.8I, J and Fig. 2.11A, B), while 
RELMα was acquired normally (Fig. 2.11C). Thus, these data indicate that Bhlhe40 is a specific 
regulator of large serous cavity macrophage proliferation in response to IL-4c and that 
monocyte-derived macrophages can acquire a Bhlhe40-dependent proliferative program similar 
to that of serous cavity resident macrophages.  
 
Bhlhe40 regulates LPM proliferation in response to H. polygyrus 
The intestinal helminth Heligmosomoides polygyrus bakeri (H. polygyrus) is a natural mouse 
pathogen that elicits robust proliferation of LPMs following oral infection (Ruckerl and Allen, 
2014). Infection with H. polygyrus caused a 4-fold increase in the number of LPMs in infected 
Bhlhe40+/+ mice compared to Bhlhe40-/- mice after 8 days (Fig. 2.12A, B). Similar findings were 
obtained in LysM-Cre- Bhlhe40fl/fl and LysM-Cre+ Bhlhe40fl/fl mice (Fig. 2.12B). Furthermore, 
after H. polygyrus infection, the proportions of BrdU+ LPMs and pHH3+ LPMs were reduced in 
Bhlhe40-/- and LysM-Cre+ Bhlhe40fl/fl compared to Bhlhe40+/+ and LysM-Cre- Bhlhe40fl/fl mice 
(Fig. 2.12C, D). H. polygyrus infection elicited a greater increase in the fraction of LPMs in the 
G1, S and G2M phases of the cell cycle in Bhlhe40+/+ compared to Bhlhe40-/- mice (Fig. 2.12E). 
The proportion of 7-AAD+ necrotic LPMs was also increased in Bhlhe40-/- and LysM-Cre+ 
Bhlhe40fl/fl compared to Bhlhe40+/+ and LysM-Cre- Bhlhe40fl/fl infected mice (Fig. 2.12F). These 




Bhlhe40 controls cell cycle-related transcription 
To determine the effects of Bhlhe40 on the expression profile of LPMs during type 2 immunity, 
we performed gene expression microarrays on sorted LPMs from IL-4c-treated Bhlhe40+/+, 
Bhlhe40-/- and LysM-Cre+ Bhlhe40fl/fl mice after 4 days. More genes (254; Fig. 2.13A, B) were 
differentially expressed by 2-fold or more between LPMs from IL-4c-treated Bhlhe40+/+ and 
Bhlhe40-/- mice compared to LPMs from naive Bhlhe40+/+ and Bhlhe40-/- mice (87 genes; Fig. 
2.13A-C). To ask whether the transcriptional changes that occurred in alternatively activated 
LPMs were dependent on Bhlhe40, we selected the 55 genes most differentially expressed (≥10-
fold different) between naive and IL-4c-treated Bhlhe40+/+ LPMs, including Mgl2, Chil3, Arg1 
and Il1rl1 (Fig. 2.13D). These genes were generally normally expressed in Bhlhe40+/+, Bhlhe40-/- 
and LysM-Cre+ Bhlhe40fl/fl LPMs from IL-4c-treated mice (Fig. 2.13D), and we also found no 
defect in the expression of Myo18a, C1qa, C1qb and C1qc, which encode known regulators of 
LPM proliferation during type 2 immune responses (Minutti et al., 2017) (Fig. 2.14A). 
Consistent with impaired proliferation, Maf (3.2-fold) and Mafb (3.8-fold) were more highly 
expressed in Bhlhe40-/- compared to Bhlhe40+/+ LPMs by qRT-PCR (Fig. 2.13E). Gene set 
enrichment analysis (GSEA) for Hallmark gene sets (Liberzon et al., 2015) showed prominent 
enrichment of gene sets related to proliferation, including the E2F targets and Myc targets v1 
gene sets in the gene expression data between LPMs from IL-4c-treated Bhlhe40+/+ and Bhlhe40-
/- mice (Fig. 2.13F). Further comparison of differentially expressed genes to the C5 gene 
ontology sets indicated that LPMs from IL-4c-treated Bhlhe40+/+ mice were substantially 
enriched for cell cycle and chromosome-related gene sets (Cell cycle, Cell cycle process, Mitotic 
cell cycle), while LPMs from IL-4c-treated Bhlhe40-/- mice showed enrichment for the Vacuole 
gene set (Fig. 2.13G-I), consistent with increased vacuolar area by electron microscopy. 
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Therefore, Bhlhe40 was required in LPMs for normal regulation of cell cycle-related gene 
expression. 
 
Bhlhe40 targets cell cycle-related loci directly 
We next addressed whether Bhlhe40 regulated LPM gene expression via direct binding to gene 
loci by sorting LPMs from naïve and IL-4c-treated Bhlhe40+/+ mice after 4 days for Bhlhe40 
chromatin immunoprecipitation sequencing (ChIP-seq). Motif analysis of the called peaks 
identified the expected CACGTG E-box sequence (Fig. 2.15A) and a majority of Bhlhe40 peaks 
(naïve 2,245 total peaks; IL-4c-treated 5,011 total peaks) were promoter-associated in both 
samples (Fig. 2.15B). In both conditions, Bhlhe40 bound sites in the Bhlhe40 (single peak, 
within promoter) and Il10 (single peak, 1 kilobase (kb) downstream of locus) loci previously 
described in T cells (Fig. 2.14B and Fig. 2.15C) (Huynh et al., 2018). We also identified a novel 
Bhlhe40 binding site 1.5kb downstream of the Bhlhe40 locus that was occupied only in LPMs 
from IL-4c-treated mice (Fig. 2.15C). Many Bhlhe40 peaks were shared between LPMs from 
naïve and IL-4c-treated mice (1,684 sites, including peaks proximal to the Klf4, Nr1d1, Plac8 
and Yy1 loci) (Fig. 2.15D), but the majority were unique to LPMs from IL-4c-treated mice 
(3,364 sites, including peaks proximal to the Klf4 and Nr1d1 loci) (Fig. 2.15D), often in 
association with shared peaks (as for the Bhlhe40 locus). 
Because Bhlhe40 and PU.1 may cooperate in LPMs (Gosselin et al., 2014), we compared 
our ChIP-seq data with previously published PU.1 ChIP-seq performed on LPMs from naïve 
C57BL/6 mice (Gosselin et al., 2014). PU.1 peaks overlapped with 22% or 24% of Bhlhe40 
peaks in LPMs from naïve or IL-4c-treated mice, respectively, including the Clec10a, Ccl2 and 
Plac8 loci (Fig. 2.14C, D and Fig. 2.15E, F). However, the majority of Bhlhe40 peaks (naïve 
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1,754 peaks; IL-4c 3,822 peaks) were not associated with PU.1 binding (Fig. 2.15F), including at 
the Bhlhe40, Maf and Il10 loci. When we assessed whether Bhlhe40 bound directly to genes with 
Bhlhe40-dependent expression, we found that Bhlhe40 bound a small fraction of genes 
differentially expressed by two-fold or more between LPMs from naïve Bhlhe40+/+ and Bhlhe40-
/- mice (11% of genes downregulated in Bhlhe40-/- LPMs, 17% of genes upregulated in Bhlhe40-/- 
LPMs, Fig. 2.14E and Fig. 2.15G) and bound a greater fraction of genes differentially expressed 
between LPMs from IL-4c-treated Bhlhe40+/+ and Bhlhe40-/- mice (15% of genes downregulated 
in Bhlhe40-/- LPMs, 48% of genes upregulated in Bhlhe40-/- LPMs, Fig. 2.14E and Fig. 2.15G), 
suggesting a direct role for Bhlhe40 in regulating gene expression in LPMs. 
Further analysis of our ChIP-Seq data identified a Bhlhe40 peak within the Maf promoter 
in LPMs from naïve or IL-4c-treated mice (Fig. 2.15H), as well as two additional peaks closest 
to the Maf locus (200kb downstream (naïve and IL-4c) and 300kb downstream (IL-4c) of the 
locus) (Fig. 2.14F), suggesting that Bhlhe40 repressed the Maf locus. There was no clear 
Bhlhe40 peak uniquely associated with the Mafb locus (Fig. 2.14G, H). To address whether 
Bhlhe40 directly regulated other cell cycle-related loci, we performed GSEA analysis for the 
subset of genes directly bound by Bhlhe40 using the gene expression data from LPMs from IL-
4c-treated Bhlhe40+/+ and Bhlhe40-/- mice. We found that differential expression of these genes 
between Bhlhe40+/+ and Bhlhe40-/- LPMs from IL-4c-treated mice largely recapitulated the 
enrichment of cell cycle-related modules observed when all gene expression data were analyzed 
(Fig. 2.15I and Fig. 2.16). Thus, Bhlhe40 functioned in LPMs as a direct transcriptional 





Here we found that the transcription factor Bhlhe40 was an essential cell-intrinsic regulator of 
proliferation in LPMs. In the steady-state, Bhlhe40-/- LPMs were reduced in number and a higher 
proportion accumulated in the G1 phase compared to Bhlhe40+/+ LPMs. During type 2 immunity, 
Bhlhe40 was essential for normal proliferation and accumulation, with a reduced proportion of 
Bhlhe40-/- LPMs in the S and M phases compared to Bhlhe40+/+ LPMs, but Bhlhe40 was 
dispensable for acquisition of alternative activation markers. Bhlhe40 mediated repression of 
Maf and activation of multiple proliferation-related loci to allow LPM cell cycling. Bhlhe40 was 
a tissue-specific regulator of proliferation of LPMs, but could be acquired by peritoneal 
monocyte-derived macrophages to support a proliferative program. 
How deletion of Bhlhe40 impairs cell cycle progression of LPMs remains unclear. We 
observed that a higher proportion of Bhlhe40-/- LPMs were Ki67+ compared to Bhlhe40+/+ LPMs, 
suggesting that Bhlhe40-/- LPMs might inappropriately enter the cell cycle. However, our data 
are not consistent with this notion, as we saw a selective increase in the proportion of Bhlhe40-/- 
LPMs in the G1 phase, without a commensurate increase in LPMs in the S, G2, or M phases. 
Both Bhlhe40+/+ and Bhlhe40-/- LPMs upregulated cyclins and CDKs when mice were treated 
with IL-4c. In contrast, Bhlhe40+/+ and Bhlhe40-/- LPMs had low expression of cyclins and CDKs 
at steady-state. These data support the notion that impaired progression from the G1 phase rather 
than enhanced proliferation was the primary cause of accumulation of G1 phase LPMs in naïve 
and likely IL-4c-treated Bhlhe40-/- mice. As expression of cyclin D and CDKs were comparable 
between Bhlhe40+/+ and Bhlhe40-/- LPMs, alterations solely in the expression of these regulators 
likely do not explain the effect of Bhlhe40 deficiency on LPM proliferation. Instead, the 
phenotype of Bhlhe40-/- LPMs was probably due to the impaired transcriptional regulation of a 
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broad set of cell cycle-related genes caused by loss of Bhlhe40 and upregulation of c-Maf and 
MafB. 
Bhlhe40 and c-Maf may functionally interact in T cells (Huynh et al., 2018; Yu et al., 
2018). Our data suggest that Bhlhe40 is a transcriptional repressor of Maf in LPMs. In contrast to 
T cells and other tissue-resident macrophages, LPMs require Bhlhe40 to support normal 
proliferation, suggesting that Bhlhe40-mediated repression of Maf has distinct effects in different 
cell types. Expression of both Bhlhe40 and c-Maf in LPMs results in a unique regulatory 
interaction not detected in macrophage subsets lacking expression of one of these transcription 
factors. Downregulation of Maf and Mafb expression is critical for proliferation in macrophages 
(Aziz et al., 2009; Soucie et al., 2016). Our data are most consistent with a role for Bhlhe40 in 
repressing Maf and Mafb to permit LPM cell cycling, along with Bhlhe40-mediated regulation of 
a wider set of target genes, some of them co-bound by PU.1, as previously proposed (Gosselin et 
al., 2014). It is likely that specific networks of integrated transcriptional regulators control the 
development and function of resident macrophages in each tissue. In LPMs, this network would 
include Bhlhe40, PU.1 (Gosselin et al., 2014), c-Maf and MafB (Soucie et al., 2016), as well as 
Gata6 (Rosas et al., 2014; Gautier et al., 2014; Okabe and Medzhitov, 2014) and C/EBPβ (Cain 
et al., 2013), two transcription factors whose loss results in impaired development of LPMs. 
In addition to LPMs and large pleural macrophages, AMs and, in some contexts, 
monocyte-derived macrophages expressed Bhlhe40. Bhlhe40-/- AMs only showed minor 
transcriptional differences compared to Bhlhe40+/+ AMs and no evidence of a proliferative 
defect. c-Maf and MafB were poorly expressed in AMs (Soucie et al., 2016) and were not 
induced in Bhlhe40-/- AMs (data not shown), suggesting that Bhlhe40 was not required to repress 
these transcription factors in AMs. It is also possible that Bhlhe41, which is expressed highly in 
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AMs but not LPMs (data not shown) and can partially substitute for Bhlhe40 (Kreslavsky et al., 
2017), may compensate for the absence of Bhlhe40 in AMs. In contrast to AMs, monocyte-
derived macrophages can acquire a Bhlhe40-dependent proliferative program in response to 
thioglycollate and IL-4c. The similarities of this Bhlhe40-regulated transcriptional program in 
monocyte-derived macrophages to that of LPMs remain to be explored.  
Whether common regulators can control macrophage cell cycling in response to different 
stimuli during homeostasis (e.g. CSF-1) or type 2 immunity (e.g. IL-4, IL-5, or IL-13) (Jenkins 
et al., 2013) is unclear. Our findings demonstrate the existence of shared regulation of 
macrophage proliferation in the steady-state and disease, as well as a crucial role for tissue-
specific transcriptional regulation acting in concert with more broadly shared regulators like c-
Maf. This suggests the possibility of therapeutically targeting the proliferation of select 
macrophage populations, including tumor-associated macrophages (TAMs), which are known to 
partly derive from tissue-resident macrophages and locally proliferate (Franklin et al., 2016; Zhu 
et al., 2017; Loyher et al., 2018; Mantovani et al., 2017). 
Our results illustrate the complexity of tissue-specific control of macrophages, 
demonstrating that tissue-specific transcription factors are critical for the regulation of 
macrophage proliferation in health and disease. Our data provide direct evidence that resident 
macrophages are under constant control by a partnership of shared and tissue-specific 
transcription factors, with possible implications for therapies.  
 




C57BL/6 (Taconic), B6.SJL (CD45.1, Taconic or Jackson), Il10-/- (B6.129P2-Il10tm1Cgn/J, 
Jackson) and LysM-Cre (B6N.129P2(B6)-Lyz2tm1(cre)Ifo/J, Jackson) mice were obtained from the 
vendors listed. Bhlhe40-/- (10 generations backcrossed to the C57BL/6 background) (Sun et al., 
2001; Lin et al., 2014), Bhlhe40GFP+ (10 generations backcrossed to the C57BL/6 background 
(Lin et al., 2016)) and Bhlhe40fl/fl (Huynh et al., 2018) mice have been previously reported. The 
Bhlhe40GFP+ mouse strain, originally defined as STOCK Tg(Bhlhe40-EGFP)PX84Gsat/Mmucd, 
identification number 034730-UCD, was obtained from the Mutant Mouse Regional Resource 
Center (MMRRC), a NCRR-NIH funded strain repository, and was donated to the MMRRC 
by the NINDS funded GENSAT BAC transgenic project (The GENSAT Project, NINDS 
Contract #N01NS02331 to the Rockefeller University). All mice were maintained in our 
specific pathogen free animal facility. Sex-matched littermates were used for experiments 
whenever possible, although in some cases mice from multiple litters were used in a single 
experiment. All animal experiments were approved by the Animal Studies Committee of 
Washington University in St. Louis. 
 
Bone marrow chimeras 
Bhlhe40+/+ CD45.1/CD45.2 mice were lethally irradiated with 1,000 rads from a gamma 
irradiator, followed by same-day i.v. transfer of 16 million total bone marrow cells (8 million 
Bhlhe40+/+ (CD45.1) cells plus either 8 million Bhlhe40+/+ (CD45.2) or Bhlhe40-/- (CD45.2) 
cells). Mice were given drinking water containing sulfamethoxazole (1.3 mg/ml) and 
trimethoprim (0.26 mg/ml) for 2 weeks after irradiation and were allowed to reconstitute for at 
least 8 weeks. In some experiments, chimeras were also made with CD45.1 recipients using 




Peritoneal cell transfers 
Peritoneal cells were lavaged from the peritonea of Bhlhe40+/+ (CD45.1), Bhlhe40+/+ (CD45.2), 
and Bhlhe40-/- (CD45.2) donors, and aliquots of cells were analyzed by flow cytometry to 
determine the frequency of LPMs. Bulk peritoneal cells were then transferred i.p. into resting 
Bhlhe40+/+ recipients (CD45.1/CD45.2) at ratios resulting in the transfer of equal numbers of 
LPMs from each donor (200,000-300,000 LPMs). 
 
Treatment of mice with thioglycollate and interleukin-4 complexes (IL-4c) 
A 3% solution of thioglycollate was prepared in water, autoclaved and aged for three or more 
months (Gautier et al., 2013). Mice received 1 ml i.p. to induce peritonitis or a control injection 
of PBS (Gautier et al., 2013). IL-4c were prepared fresh as described (Finkelman et al., 1993; 
Jenkins et al., 2011). IL-4 (Shenandoah Biotechnology #200-18, resuspended in 0.1% BSA in 
water) and anti-IL-4 antibody (clone 11B11; Leinco I-1071 or BioXCell BE0045) were 
combined in a 1:5 ratio by mass and a 1:1 ratio by volume, using ~1 mg/ml cytokine and ~5 
mg/ml antibody. Complexes were incubated for ~2 minutes at room temperature (RT), diluted in 
1x Dulbecco's PBS (DPBS) and injected i.p. Control injections were 0.1% BSA diluted in 1x 
DPBS, while naïve mice were also used for assessment of cell cycling, due to acquisition of 
Ki67+ by LPMs 2 days after PBS injection as described (Jenkins et al., 2013). Mice received 
injections on day 0 and day 2, followed by sacrifice on day 4 as described (Jenkins et al., 2011). 
For treatment with thioglycollate and IL-4c complexes, mice were injected i.p. with 
thioglycollate on day 0 and IL-4c on days 0 and 2, as previously described (Gundra et al., 2014; 




H. polygyrus infections 
H. polygyrus bakeri third-stage larvae (L3) were prepared as described (Camberis et al., 2003). 
Mice were orally gavaged with 200 L3 or water (mock) with a 20-gauge ball-tipped gavage 
needle. Mice were sacrificed on day 8 of infection for assessment of peritoneal cells. 
 
Leukocyte collection from tissues 
Peritoneal and pleural cells were collected from body cavities by lavage. Bone marrow was 
collected by flushing hind limb femurs and tibias. Blood was collected by submandibular 
bleeding into EDTA or lithium heparin tubes. Lungs, liver, spleen and kidney were excised, 
placed in Iscove's Modified Dulbecco's Medium (IMDM) containing 5% fetal bovine serum 
(FBS), minced finely, and digested at 37 ⁰C for an hour with mechanical disruption with a stir 
bar and enzymatic digestion (lung and kidneys, 4 mg/ml collagenase D (Roche); spleen, 0.25 
g/ml collagenase B (Roche) and 30U/ml DNase I (EMD); liver, 4 mg/ml collagenase D and 
30U/ml DNase I). Microglia (Lin et al., 2016) and small intestinal lamina propria cells (Bando et 
al., 2018) were isolated as described. After digestion, enzymes were inactivated with 5 mM 
EDTA and samples were incubated on ice for 5 minutes. 
All cells were passed through a 70 μm cell strainer before analysis. If necessary, tissues 
were treated with ACK lysis buffer to lyse red blood cells. Cells were counted with a 





Cell surface staining was conducted in sterile 1x PBS with 0.5% BSA and 2 mM EDTA 
(hereafter FACS buffer). In brief, cells were washed in FACS buffer, blocked with α-CD16/32 
(clone 2.4G2, BioXCell) for 10 minutes at 4 ⁰C, stained for 20 min at 4 ⁰C and washed with 
FACS buffer before flow cytometry. In some experiments to assess cell death, 7-AAD (1:20 of a 
50 μg/mL solution, BioLegend or BD) was added to cells for 15 minutes prior to flow cytometry. 
Flow cytometry was performed on FACSCanto II, LSRFortessa, LSRFortessa X20 and LSR II 
instruments (all BD). FlowJo software (Treestar) was used for analysis. 
Gating of cell populations was as follows (all analysis pre-gated on FSC/SSC and a FSC-
W/FSC-A singlet gate). Blood monocytes were gated as Ly6G-CD115+ and then divided by 
Ly6C expression. Peritoneal and pleural macrophages were gated as CD115+CD11b+, then 
divided into ICAM2+MHC-IIint large macrophages and ICAM2-MHC-II+ small macrophages. 
Thioglycollate-elicited macrophages were gated as CD115+CD11b+ICAM2lo. Liver Kupffer cells 
were gated as CD45+CD11bloF4/80hi, and in some contexts as Ly6C-. Kidney macrophages were 
gated as CD45+Ly6C-CD11b+F4/80hi. AMs were gated as CD45+Siglec-F+CD11c+, and in some 
contexts as F4/80+CD11b-. Red pulp macrophages were gated as F4/80hi and negative or low for 
other markers (CD11blo, MHC-IIlo, or CD11clo). Microglia were gated as CD45intCD11b+. Small 
intestinal lamina propria macrophages were gated as CD45+Ly6C-F4/80+CD64+MHC-II+. 
Peritoneal B cells were gated as CD115-MHC-II+CD19+. Analysis of cells from the Bhlhe40GFP+ 
reporter mouse used viability dyes (Po pro 1 or 7-AAD) when necessary to exclude dead cells. 
 
Intracellular staining for flow cytometry 
For Ki67, DAPI, RELMα, BrdU and pHH3 staining, the eBioscience FoxP3/Transcription Factor 
Staining Buffer set (00-5523-00) or the BioLegend True-Nuclear Transcription Factor Buffer set 
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(424401) was used. In brief, after surface staining, cells were fixed with 1x Fix Concentrate 
buffer in provided Fix Diluent for 30 minutes at 4 ⁰C. Cells were then washed with FACS buffer 
and stored overnight. To permeabilize the cells, samples were washed with 1x Perm buffer 
diluted in water. Following blocking with 2% rat serum, samples were stained for 1 hour at RT, 
except for DAPI and secondary antibodies (20 minutes at RT), followed by washing in 1x Perm 
buffer and FACS buffer before flow cytometry. 
For BrdU staining, mice were given 1 mg of BrdU i.p. (from BD kit, 552598, or Sigma, 
B5002) three hours before sacrifice as described (Jenkins et al., 2011). After sacrifice of mice 
and peritoneal lavage, samples were processed, fixed and stored overnight as for other 
intracellular antigens. BrdU-labelled cells were washed in 1x Perm buffer, incubated in DNase I 
(from BD kit, 552598 or Sigma, D4513) in 1x DPBS for 30 min at 37 ⁰C, washed in 1x Perm 
buffer, blocked with 2% rat serum and stained for 1 hour at RT with α-BrdU antibody (BD, 
552598), followed by washing in 1x Perm buffer and FACS buffer. Mice that did not receive 
BrdU were used as negative controls. 
 
Transmission electron microscopy 
For ultrastructural analyses, peritoneal cells were fixed in 2% PFA/2.5% glutaraldehyde 
(Polysciences Inc.) in 100 mM sodium cacodylate buffer, pH 7.2 for 1 hour at RT. Samples were 
washed in sodium cacodylate buffer at RT and postfixed in 1% osmium tetroxide (Polysciences 
Inc.) for 1 hour. Samples were rinsed in distilled water prior to en bloc staining with 1% aqueous 
uranyl acetate (Ted Pella Inc.) for 1 hour. Following rinsing in distilled water, samples were 
dehydrated in a graded series of ethanol and embedded in Eponate 12 resin (Ted Pella Inc.). 
Sections of 95 nm were cut with a Leica Ultracut UCT ultramicrotome, stained with uranyl 
acetate and lead citrate and viewed on a JEOL 1200 EX transmission electron microscope (JEOL 
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USA Inc.) equipped with an AMT 8 megapixel digital camera and AMT Image Capture Engine 
V602 software (Advanced Microscopy Techniques). 
For morphological analysis, images were blinded and randomized. LPMs were identified 
as large cells with abundant cytoplasm and were distinguished from rare peritoneal mast cells by 
the absence of electron-dense granules. For measurement statistics, the ObjectJ plugin was used 
in ImageJ software (NIH). In brief, cell and vesicle cross-sectional area were calculated by 
tracing the outline of the cell or vesicles, respectively, and calculating the enclosed area. ER 
cross-sectional extent was calculated by tracing the ER with lines and adding these lengths 
together. For assessment of ER luminal width, a randomly placed grid was used to subdivide the 
cell into sections. Representative measurements were then taken across the lumen of the ER, and 
the measurements from each section were averaged. 
 
Microarrays 
The following cell populations were sorted on a FACSAria II (BD) into FBS: for naïve LPM 
microarrays, B220-F4/80+CD11b+ICAM2+ LPMs from untreated mice; for in vivo IL-4c-
stimulated LPM microarrays, CD115+CD11b+ICAM2+MHC-IIint LPMs from mice treated with 
IL-4c at days 0 and 2, with peritoneal cells collected at day 4; for naïve AM microarrays, 
CD45+Ly6G-Siglec-F+CD11c+CD11blo AMs from untreated mice. Cells were lysed and RNA 
was purified using the E.Z.N.A. MicroElute Total RNA kit (Omega Bio-Tek). Total RNA was 
submitted to the Genome Technology Access core at Washington University for cDNA synthesis 
(NuGen Pico SL) followed by microarray analysis on the Affymetrix Mouse Gene 1.0 ST 
platform. Data were analyzed using the DNASTAR ArrayStar program. Genes with an 
expression value of <5 (in log 2 scale) in all replicates were considered not expressed. For 
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analysis of naïve microarrays, which were conducted on three biologic replicates, the 
differentially expressed gene list was also filtered on genes with a p-value significance of ≤0.05 
by the moderated t-test. For analysis of in vivo IL-4c-stimulated LPM microarrays, which were 
conducted on two biologic replicates, no p-value filtering was applied. For comparison of naïve 
to in vivo IL-4c-stimulated LPMs, CEL files were normalized together to generate expression 
data. Heatmaps were generated with Morpheus (software.broadinstitute.org/morpheus/). Venn 
diagrams were generated with the Venn Diagram Plotter tool (Pacific Northwest National 
Laboratories, omics.pnl.gov). Multiple differentially expressed probe sets representing a single 
gene were presented in heat maps without exclusion, but only unique genes were counted in 
Venn diagrams. 
The macrophage alternative activation gene signature used to assess naïve macrophages 
was generated from GSE69607 comparing M0, M1 and M2 bone marrow-derived macrophages 
(BMDMs) (Jablonski et al., 2015). The 29 genes 20-fold upregulated in M2 vs. M1 BMDMs 
were used to define a set of macrophage alternative activation-related genes. The LPM gene 
signature was previously published (Gautier et al., 2012). For the LPM alternative activation 
gene signature used to assess in vivo IL-4c-stimulated LPMs, we compared our microarray data 
from naïve and in vivo IL-4c-stimulated Bhlhe40+/+ LPMs and defined an alternative activation 
signature for LPMs, composed of the 55 unique genes up- or down-regulated by ten-fold or 
more. For comparison of the gene expression signature of Bhlhe40- or Gata6-deficient LPMs, 
our data was analyzed in parallel with GSE37448 (Gautier et al., 2014) as above, as both data 
sets were generated on the Affymetrix Mouse Gene 1.0 ST platform. 
 
Quantitative real-time polymerase chain reaction (qRT-PCR) 
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LPMs were sorted as for microarrays. RNA was isolated with the E.Z.N.A. MicroElute Total 
RNA kit (Omega Bio-Tek), and cDNA was synthesized with 50 ng RNA using the High 
Capacity RNA to cDNA kit (Invitrogen). RNA concentration was assessed with a Nanodrop 
2000 spectrophotometer (ThermoFisher). qRT-PCR was performed with Power SYBR Green 
PCR Master Mix (Applied Biosystems) using a StepOnePlus Real-Time PCR machine (Applied 
Biosystems). Gene expression was determined relative to Hprt by the ΔCT method. The 
following primers were used: Hprt, forward 5′-TCAGTCAACGGGGGACAT AAA-3′, reverse 
5′-GGGGCTGTACTGCTTAACCAG-3′; Maf forward 5’-GGAGACCGACCGCATCATC-3’ 
reverse 5’-TCATCCAGTAGTAGTCTTCCAGG-3’; Mafb forward 5’-
TTCGACCTTCTCAAGTTCGACG-3’, reverse 5’-TCGAGATGGGTCTTCGGTTCA-3'. 
 
Immunoblotting 
LPMs were sorted as for microarrays, pooled from multiple mice and lysed at a concentration of 
25 million cells/mL using the RIPA lysis buffer system (Santa Cruz Biotechnology). Laemmli 
buffer (Bio-Rad, with added 2-mercaptoethanol) was added to the samples, which were then 
boiled for 10 minutes, and run on a Bio-Rad Miniprotean TGX gel with Precision Plus Dual 
Color molecular weight standards (Bio-Rad). Proteins were transferred to a BioBlot 
polyvinylidine fluoride membrane (Costar). Blots were blocked for 1-2 hours with 5% milk, 
followed by overnight staining with primary antibodies in 5% milk at 4 ⁰C with shaking. After 
washing, blots were stained with horseradish peroxidase-conjugated secondary antibodies for 45-
60 minutes at RT with shaking. After washing, blots were developed with either Super Signal 
West Femto Maximum Sensitivity Substrate (Thermo Fisher) or Clarity Western ECL Substrate 
(Bio-Rad). Images were captured on a Chemidoc system (Bio-Rad) and inverted on Adobe 
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Illustrator for presentation. Blots were stripped with Restore PLUS Western Blot Stripping 
Buffer (ThermoFisher). Blots were then washed, reblocked and restained. 
 
Gene set enrichment analysis 
Lists of differentially expressed genes (≥1.5-fold up- or downregulated) were cross-referenced to 
the C5 gene sets in the MSigDB database. To further examine the enrichment of gene sets, the 
GSEA software from the Broad Institute was used to analyze all expressed genes or all Bhlhe40-
bound expressed genes for gene set enrichment using the Hallmark and C5 databases 
(Subramanian et al., 2005; Liberzon et al., 2015). 
 
ChIP-Seq 
Anti-Bhlhe40 ChIP-seq was performed as previously published (Huynh et al., 2018). LPMs were 
sorted as for microarrays and pooled from multiple mice. Cells were fixed for 10 min at RT in 
1% PFA with shaking. Cross-linking was stopped with glycine added to 0.125 M, cells were 
pelleted and dry pellets were stored at -80 ⁰C. Cross-linked chromatin was sonicated and 
immunoprecipitated using rabbit anti-Dec1 (Bhlhe40) antibody (NB100-1800, Lot C1; Novus 
Biologicals). Following immunoprecipitation, the GenElute PCR cleanup kit (Sigma) was used 
to purify DNA. Library construction was followed by single-read sequencing on a HiSeq3000 
(Illumina) at the Genome Technology Access Center at Washington University in St. Louis. 
Read length was 50 base pairs (bp). Quality control of FASTQ files used FastQC (0.11.3). 
Bowtie (1.1.1) was used to map reads onto the mm10 mouse reference genome. Input DNA 
samples were used for peak calling on Bhlhe40-immunoprecipitation samples using MACS v1.4 
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with default settings (Zhang et al., 2008). Generated peaks were additionally required to have 
fold-enrichment ≥5 and reads from unmapped regions (chrUn_xxxxx) were excluded. 
Normalized tracks were generated with Deeptools (2.5.3), and tracks were visualized 
with the UCSC Genome Browser. Discriminative Regular Expression Motif Elicitation 
(DREME) (5.0.1) (Bailey, 2011) was used for motif enrichment analysis using 250 bp flanked 
summits of all acquired peaks. To annotate peaks, R package ChIPseeker (1.14.1) was used. The 
intersect function from the BEDtools suite (v2.25.0) was used to find shared peaks. The shared 
peak count was defined as the number of overlapping peaks in the naïve LPM Bhlhe40 ChIP-seq 
sample compared to the in vivo IL-4c-stimulated LPM Bhlhe40 ChIP-seq sample. Two group 
Venn diagrams were generated with the Venn Diagram Plotter tool. 
ChIP-seq data for PU.1 performed on LPMs (GSM1533894) and the corresponding input 
sample (GSM1533895) (Gosselin et al., 2014) were downloaded in SRA format and converted to 
FASTQ format using the fastq-dump function (v2.8.1) from the SRA Toolkit. Subsequent 
processing and filtration was performed as described above. The shared peak count was defined 
as the number of overlapping peaks in the naïve LPM Bhlhe40 ChIP-seq sample compared to 
each of the other samples, except for the comparison of in vivo IL-4c-stimulated LPM Bhlhe40 
ChIP-seq and LPM PU.1 ChIP-seq samples, which was defined as the number of overlapping 
peaks in the IL-4c Bhlhe40 sample. Three group Venn diagrams were generated with the 
eulerAP3 v3 tool (www.eulerdiagrams.org/eulerAPE/) (Micallef and Rodgers, 104). 
 
Statistical analysis 
All data are from at least two independent experiments, unless otherwise indicated. Data were 
analyzed by paired or unpaired two-tailed Student’s t-tests (Prism 7; GraphPad Software, Inc.) as 
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indicated in the figure legends, with p ≤ 0.05 considered significant. For relevant comparisons 
where no p-value is shown, the p-value was > 0.05. For analysis of gene lists against the 
MSigDB database, the hypergeometric test performed by the Investigate Gene Sets tool was used 
to determine significance. For GSEA analysis, the NES score calculated by the GSEA software 
was used to account for set size effects when determining enrichment. The GSEA-calculated 
FWER p-value was used to determine significance, as this statistic is more conservative than the 
False Discovery Rate (FDR). Horizontal bars represent the mean and error bars represent the 





Figure 2.1. Loss of Bhlhe40 dysregulates the cell cycle in LPMs. (A) Flow cytometry of 
Bhlhe40GFP transgene reporter expression in blood monocytes (representative of 2 
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experiments, n=5 Bhlhe40GFP+, 2 Bhlhe40GFP-); red pulp macrophages, microglia, Kupffer 
cells, kidney macrophages, SI macrophages, and peritoneal macrophages (representative of 2 
experiments, n=4 Bhlhe40GFP+, 2 Bhlhe40GFP-); and AMs (representative of 3 experiments, 
n=6 Bhlhe40GFP+, 3 Bhlhe40GFP-) from Bhlhe40GFP+ and Bhlhe40GFP- mice. (B) Flow cytometry 
of peritoneal macrophage subsets in Bhlhe40+/+ and Bhlhe40-/- mice (representative of 6 
experiments, n=22/group). (C) Numbers of LPMs as in (B), SPMs (pooled from 5 
experiments, n=19/group), AMs (pooled from 4 experiments, n=13 Bhlhe40+/+, 12 Bhlhe40-/-), 
red pulp macrophages (pooled from 3 experiments, n=9 Bhlhe40+/+, 8 Bhlhe40-/-), Kupffer 
cells, and kidney macrophages (both pooled from 2 experiments, n=10/group) from Bhlhe40+/+ 
and Bhlhe40-/- mice. (D) Flow cytometry of Ki67 expression by Bhlhe40+/+ and Bhlhe40-/- 
LPMs (representative of 7 experiments, n=24 Bhlhe40+/+, 22 Bhlhe40-/-). (E) Frequency of 
Ki67+ LPMs as in (D), SPMs, and B cells (both pooled from 8 experiments, n=30 Bhlhe40+/+, 
29 Bhlhe40-/-) from Bhlhe40+/+ and Bhlhe40-/- mice. (F) Flow cytometry of BrdU incorporation 
by Bhlhe40+/+ and Bhlhe40-/- LPMs (representative of 5 experiments, n=18/group). (G) 
Frequency of BrdU+ LPMs as in (F). (H) Flow cytometry of pHH3 expression by Bhlhe40+/+ 
and Bhlhe40-/- LPMs (representative of 4 experiments, n=12 Bhlhe40+/+, 11 Bhlhe40-/-). (I) 
Frequency of pHH3+ LPMs as in (H). (J) Flow cytometry for discrimination of cell cycle 
phases of Bhlhe40+/+ and Bhlhe40-/- LPMs (representative of 4 experiments, n=12 Bhlhe40+/+, 
11 Bhlhe40-/-). (K) Numbers of LPMs in each phase of the cell cycle as in (J). Data are mean 
± s.e.m. *P ≤ 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001, significance calculated with 
an unpaired two-sided Student’s t-test. 
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Figure 2.2. Bhlhe40 is specifically required in peritoneal and pleural macrophages. (A) 
Flow cytometry of Bhlhe40GFP transgene reporter expression in pleural macrophages from 
Bhlhe40GFP+ and Bhlhe40GFP- mice (representative of 2 experiments, n=3 Bhlhe40GFP+, 2 
Bhlhe40GFP-). (B-E) Flow cytometry for AMs (B), red pulp macrophages (C), kidney 
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macrophages (D), and Kupffer cells (E) from Bhlhe40+/+ and Bhlhe40-/- mice as in Fig. 1C. (F) 
Flow cytometry for Tim4 expression on LPMs from Bhlhe40+/+ and Bhlhe40-/- mice 
(representative of 11 experiments, n=40/group). (G) Numbers of Tim4+ LPMs as in (F). (H) 
Flow cytometry for CD226 expression on SPMs from Bhlhe40+/+ and Bhlhe40-/- mice 
(representative of 8 experiments, n=27/group). (I) Numbers of CD226+ SPMs as in (H). (J) 
Numbers of peritoneal B cells from Bhlhe40+/+ and Bhlhe40-/- mice (pooled from 12 
experiments, n=35/group). (K) Numbers of large pleural macrophages from Bhlhe40+/+ and 
Bhlhe40-/- mice (pooled from 6 experiments, n=16 Bhlhe40+/+, 17 Bhlhe40-/-). (L) Frequency of 
Ki67+ large pleural macrophages from Bhlhe40+/+ and Bhlhe40-/- mice (pooled from 3 
experiments, n=7 Bhlhe40+/+, 8 Bhlhe40-/-). (M) frequency of 7-AAD+ LPMs from Bhlhe40+/+ 
and Bhlhe40-/- mice (pooled from 8 experiments, n=19 Bhlhe40+/+, 18 Bhlhe40-/-). Data are 
mean ± s.e.m. ***P < 0.001; ****P < 0.0001, significance calculated with an unpaired two-




Figure 2.3. Bhlhe40 is cell-intrinsically required in LPMs to regulate the cell cycle. (A) 
Flow cytometry for the discrimination of donor and recipient LPMs (representative of 6 
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experiments, n=18 [Bhlhe40+/+ (CD45.1) +Bhlhe40+/+ (CD45.2)], 21 [Bhlhe40+/+ (CD45.1) 
+Bhlhe40-/- (CD45.2)]) and peritoneal B cells (representative of 4 experiments, n=12 
[Bhlhe40+/+ (CD45.1) +Bhlhe40+/+ (CD45.2)], 13 [Bhlhe40+/+ (CD45.1) +Bhlhe40-/- (CD45.2)]) 
from Bhlhe40+/+ (CD45.1) plus either Bhlhe40+/+ (CD45.2) or Bhlhe40-/- (CD45.2) mixed bone 
marrow chimeras. (B) Ratio of CD45.1 to CD45.2 LPMs as in (A). (C) Ratios of CD45.1 cells 
to CD45.2 cells for SPMs (pooled from 4 experiments, n=12 [Bhlhe40+/+ (CD45.1) 
+Bhlhe40+/+ (CD45.2)], 13 [Bhlhe40+/+ (CD45.1) +Bhlhe40-/- (CD45.2)]), peritoneal B cells as 
in (A), blood monocytes (pooled from 2 experiments, n=6 [Bhlhe40+/+ (CD45.1) +Bhlhe40+/+ 
(CD45.2)], 8 [Bhlhe40+/+ (CD45.1) +Bhlhe40-/- (CD45.2)]), red pulp macrophages, AMs (both 
pooled from 6 experiments, n=13 [Bhlhe40+/+ (CD45.1) +Bhlhe40+/+ (CD45.2)], 15 
[Bhlhe40+/+ (CD45.1) +Bhlhe40-/- (CD45.2)]), Kupffer cells, kidney macrophages (both pooled 
from 3 experiments, n=10 [Bhlhe40+/+ (CD45.1) +Bhlhe40+/+ (CD45.2)], 11 [Bhlhe40+/+ 
(CD45.1) +Bhlhe40-/- (CD45.2)]), and SI macrophages (pooled from 2 experiments, n=6 
[Bhlhe40+/+ (CD45.1) +Bhlhe40+/+ (CD45.2)], 7 [Bhlhe40+/+ (CD45.1) +Bhlhe40-/- (CD45.2)]) 
from mixed bone marrow chimeras. (D) Ratio of CD45.1 to CD45.2 large pleural 
macrophages (pooled from 2 experiments, n=6/group) from mixed bone marrow chimeras. (E) 
Flow cytometry for discrimination of cell cycle phases of Bhlhe40+/+ (CD45.1), Bhlhe40+/+ 
(CD45.2), or Bhlhe40-/- (CD45.2) LPMs from mixed bone marrow chimeras (representative of 
3 experiments, n=9 [Bhlhe40+/+ (CD45.1) +Bhlhe40+/+ (CD45.2)], 11 [Bhlhe40+/+ (CD45.1) 
+Bhlhe40-/- (CD45.2)]). (F) Frequency of G1 LPMs as in (E) with LPMs from each donor 
recovered from the same recipient connected by a line. (G) Numbers of LPMs, SPMs (both 
pooled from 6 experiments, n=14 LysM-Cre- Bhlhe40fl/fl, 15 LysM-Cre+ Bhlhe40fl/fl) and 
peritoneal B cells (5 experiments, n=12 LysM-Cre- Bhlhe40fl/fl, 13 LysM-Cre+ Bhlhe40fl/fl) from 
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LysM-Cre- Bhlhe40fl/fl and LysM-Cre+ Bhlhe40fl/fl mice. (H) Flow cytometry for discrimination 
of cell cycle phases of LysM-Cre- Bhlhe40fl/fl and LysM-Cre+ Bhlhe40fl/fl LPMs (representative 
of 3 experiments, n=8/group). (I) Numbers of LPMs in each phase of the cell cycle as in (H). 
(J) Flow cytometry for the discrimination of donor and recipient LPMs and peritoneal B cells 
from CD45.1/CD45.2 recipients of mixed peritoneal cells transferred from Bhlhe40+/+ 
(CD45.1) plus either Bhlhe40+/+ (CD45.2) or Bhlhe40-/- mice (CD45.2) mice (representative of 
2 experiments, n=3 [Bhlhe40+/+ (CD45.1) +Bhlhe40+/+ (CD45.2)], 5 [Bhlhe40+/+ (CD45.1) 
+Bhlhe40-/- (CD45.2)]). (K, L) Ratio of CD45.1 LPMs to CD45.2 LPMs (K) and CD45.1 
peritoneal B cells to CD45.2 peritoneal B cells (L) as in (J) (pooled from 2-3 experiments, 
n≥3 for all time points, except day 14 [Bhlhe40+/+ (CD45.1) +Bhlhe40+/+ (CD45.2)], n=2). 
Data are mean ± s.e.m. *P ≤ 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001, significance 
calculated with an unpaired two-sided Student’s t-test, except in (F) which used an unpaired 
two-sided Student’s t-test. 
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Figure 2.4. Bhlhe40 is cell-intrinsically required in LPMs. (A) Ratio of CD45.1 to CD45.2 
cells for small pleural macrophages and pleural B cells from mixed bone marrow chimeras as 
in Fig. 2D. (B) Flow cytometry for the discrimination of donor and recipient LPMs and 
peritoneal B cells from CD45.1/CD45.2 recipients of transferred peritoneal cells as in Fig. 
2K, L. (C, D) Gene expression microarray data from Bhlhe40+/+ and Bhlhe40-/- LPMs (in this 
study) and LysM-Cre- Gata6fl/fl, and LysM-Cre+ Gata6fl/fl LPMs (reanalyzed from Gautier et 
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al., 2014) were analyzed for shared and unique Bhlhe40 and/or Gata6-dependent genes (≥2-
fold differentially expressed, depicted as a Venn diagram) (C) and differentially expressed 
genes dependent on both Bhlhe40 and Gata6 (D). (E) Gene expression microarray data were 
analyzed for expression of an LPM gene signature in LPMs and AMs from Bhlhe40+/+ and 
Bhlhe40-/- mice. Microarray data from LPMs (n=3/group) and AMs (n=2/group) are from a 





Figure 2.5. Bhlhe40 regulates a distinct set of genes related to alternative activation in 
LPMs. (A, B) Gene expression microarray data were analyzed for genes differentially 
expressed by ≥2-fold (A) and expression of a macrophage alternative activation gene 
signature in Bhlhe40+/+ and Bhlhe40-/- LPMs (B). (C) Flow cytometry of Embigin-1 expression 
55 
 
and quantitation of geometric mean fluorescence intensity (gMFI) on LPMs (pooled from 4 
experiments, n=8 Bhlhe40+/+, 7 Bhlhe40-/-; 1 experiment, n=3 LysM-Cre- Bhlhe40fl/fl, 4 LysM-
Cre+ Bhlhe40fl/fl). (D) Flow cytometry of Clec10a expression and frequency of Clec10a+ 
LPMs (pooled from 6 experiments, n=19 Bhlhe40+/+ and 21 Bhlhe40-/-; 4 experiments, n=10 
LysM-Cre- Bhlhe40fl/fl and LysM-Cre+ Bhlhe40fl/fl). (E) Flow cytometry of Lyve-1 expression 
and frequency of Lyve-1+ LPMs (pooled from 7 experiments, n=22 Bhlhe40+/+, 24 Bhlhe40-/-; 
5 experiments, n=11 LysM-Cre- Bhlhe40fl/fl and LysM-Cre+ Bhlhe40fl/fl) from Bhlhe40+/+, 
Bhlhe40-/-, LysM-Cre- Bhlhe40fl/fl, and LysM-Cre+ Bhlhe40fl/fl LPMs. (F, G) MSigDB C5 gene 
set enrichment was analyzed using the lists of genes expressed at ≥1.5-fold in Bhlhe40+/+ vs. 
Bhlhe40-/- (G) or Bhlhe40-/- vs. Bhlhe40+/+ LPMs (G). (H) qRT-PCR of Maf and Mafb 
expression relative to Hprt in Bhlhe40+/+ and Bhlhe40-/- LPMs (pooled from 2 experiments, 
n=5 Bhlhe40+/+, 4 Bhlhe40-/-). (I) Gene expression microarray data were analyzed for shared 
and unique Bhlhe40-dependent genes in Bhlhe40+/+ and Bhlhe40-/- LPMs and AMs (≥2-fold 
differentially expressed, depicted as a Venn diagram). Heat map depicts all genes 
differentially expressed by ≥2-fold in Bhlhe40+/+ and Bhlhe40-/- AMs. Microarray data from 
LPMs (n=3/group) and AMs (n=2/group) are from a single experiment. Data are mean ± 
s.e.m. *P ≤ 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001, significance calculated with an 




Figure 2.6. Bhlhe40 is required for normal accumulation of resident, but not recruited, 
macrophages in the peritoneum. (A) Flow cytometry of peritoneal macrophage subsets from 
Bhlhe40+/+ and Bhlhe40-/- mice treated with thioglycollate (Thio) (representative of 3 
experiments, n=6/group). (B) Numbers of CD115+CD11b+ peritoneal macrophages from 
Bhlhe40+/+ and Bhlhe40-/- mice treated with PBS or Thio as in (A) (pooled from 3 
experiments, n=3/group for PBS, 6/group for Thio). (C) Flow cytometry of peritoneal 
macrophage subsets from Bhlhe40+/+ and Bhlhe40-/- mice treated with IL-4c (representative of 
6 experiments, 17 IL-4c-treated Bhlhe40+/+, 19 IL-4c-treated Bhlhe40-/-). (D, E) Numbers of 
LPMs (D) and SPMs (E) as in (C) from Bhlhe40+/+, Bhlhe40-/-, LysM-Cre- Bhlhe40fl/fl, and 
LysM-Cre+ Bhlhe40fl/fl mice treated with PBS or IL-4c (pooled from 5 experiments, 6 PBS-
treated Bhlhe40+/+ and Bhlhe40-/-; IL-4c-treated as in c for Bhlhe40+/+ and Bhlhe40-/-; 2 
experiments, 2 PBS-treated LysM-Cre- Bhlhe40fl/fl; 3 PBS-treated LysM-Cre+ Bhlhe40fl/fl; 9 
IL-4c-treated LysM-Cre- Bhlhe40fl/fl; 7 IL-4c-treated LysM-Cre+ Bhlhe40fl/fl). Data are mean ± 




Figure 2.7. Further analysis of responses to IL-4c in Bhlhe40-deficient mice. (A) Flow 
cytometry of peritoneal macrophage subsets from Bhlhe40+/+, Bhlhe40-/-, and Bhlhe40-/- Il10-/- 
mice treated with PBS or IL-4c (representative of 2 experiments, n=3 PBS-treated Bhlhe40+/+, 2 
PBS-treated Bhlhe40-/-, 3 PBS-treated Bhlhe40-/- Il10-/-, 5 IL-4c-treated Bhlhe40+/+, 7 IL-4c-
treated Bhlhe40-/-, 4 IL-4c-treated Bhlhe40-/- Il10-/-). (B) Numbers of LPMs as in (A). (C) 
Immunoblotting of cyclins D1-3, cyclin-dependent kinase (CDK) 2, CDK4, CDK6, E2F2, and 
beta actin in lysates of LPMs from Bhlhe40+/+ and Bhlhe40-/- mice unstimulated or treated with 
IL-4c (representative of 2 experiments, n=2/group). (D) Frequency of BrdU+ Bhlhe40+/+ 
(CD45.1), Bhlhe40+/+ (CD45.2), or Bhlhe40-/- (CD45.2) LPMs from mixed bone marrow chimera 
mice (generated as in Fig. 2A-F) treated with PBS or IL-4c, with LPMs from each donor 
recovered from the same recipient connected by a line (pooled from 2 experiments, n=2 PBS-
treated [Bhlhe40+/+ (CD45.1) +Bhlhe40+/+ (CD45.2)] and [Bhlhe40+/+ (CD45.1) +Bhlhe40-/- 
(CD45.2)]; 4 IL-4c-treated [Bhlhe40+/+ (CD45.1) +Bhlhe40+/+ (CD45.2)]; 5 [Bhlhe40+/+ (CD45.1) 
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+Bhlhe40-/- (CD45.2)])). Data are mean ± s.e.m. ***P < 0.001, significance calculated with an 






Figure 2.8. Bhlhe40 is required for normal cycling, but not polarization, of peritoneal 
macrophages during type 2 immunity. (A-D) Frequency of RELMα+ LPMs (A) (pooled 
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from 3 experiments, n=4 PBS-treated Bhlhe40+/+ and Bhlhe40-/-; 15 IL-4c-treated Bhlhe40+/+ 
and Bhlhe40-/-; 2 experiments, 2 PBS-treated LysM-Cre- Bhlhe40fl/fl and LysM-Cre+ 
Bhlhe40fl/fl; 6 IL-4c-treated LysM-Cre- Bhlhe40fl/fl; 5 IL-4c-treated LysM-Cre+ Bhlhe40fl/fl), 
Clec10a+ LPMs (B) (pooled as in (A)), BrdU+ LPMs (C) (pooled from 3 experiments, n=4 
PBS-treated Bhlhe40+/+; 5 PBS-treated Bhlhe40-/-; 13 IL-4c-treated Bhlhe40+/+; 17 IL-4c-
treated Bhlhe40-/-; 3 PBS-treated LysM-Cre- Bhlhe40fl/fl and LysM-Cre+ Bhlhe40fl/fl; 8 IL-4c-
treated LysM-Cre- Bhlhe40fl/fl; 7 IL-4c-treated LysM-Cre+ Bhlhe40fl/fl), and pHH3+ LPMs (D) 
(pooled from 3 experiments, n=6 PBS-treated Bhlhe40+/+; 7 PBS-treated Bhlhe40-/-; 16 IL-4c-
treated Bhlhe40+/+; 18 IL-4c-treated Bhlhe40-/-; 3 PBS-treated LysM-Cre- Bhlhe40fl/fl and 
LysM-Cre+ Bhlhe40fl/fl; 8 IL-4c-treated LysM-Cre- Bhlhe40fl/fl; 6 IL-4c-treated LysM-Cre+ 
Bhlhe40fl/fl) from Bhlhe40+/+, Bhlhe40-/-, LysM-Cre- Bhlhe40fl/fl, and LysM-Cre+ Bhlhe40fl/fl 
mice treated with PBS or IL-4c. (E) Proportion of LPMs in each phase of the cell cycle from 
Bhlhe40+/+ and Bhlhe40-/- mice unstimulated or treated with IL-4c (pooled from 5 experiments, 
n=6/group for unstimulated; 16 IL-4c-treated Bhlhe40+/+; 15 IL-4c-treated Bhlhe40-/-). (F) 
Frequency of 7-AAD+ LPMs from Bhlhe40+/+, Bhlhe40-/-, LysM-Cre- Bhlhe40fl/fl, and LysM-
Cre+ Bhlhe40fl/fl mice treated with PBS or IL-4c (pooled from 3 experiments, n=5 PBS-treated 
Bhlhe40+/+ and Bhlhe40-/-; 13 IL-4c-treated Bhlhe40+/+; 17 IL-4c-treated Bhlhe40-/-; 3 PBS-
treated LysM-Cre- Bhlhe40fl/fl and LysM-Cre+ Bhlhe40fl/fl; 8 IL-4c-treated LysM-Cre- 
Bhlhe40fl/fl; 7 IL-4c-treated LysM-Cre+ Bhlhe40fl/fl). (G) Frequency of BrdU+ LPMs, large 
pleural macrophages, red pulp macrophages, Kupffer cells, and AMs from Bhlhe40+/+ and 
Bhlhe40-/- mice treated with PBS or IL-4c (pooled from 2 experiments, n=3/group for PBS; 6 
IL-4c-treated Bhlhe40+/+; 7 IL-4c-treated Bhlhe40-/-; except for pleura, 3 experiments, n=4 
PBS-treated Bhlhe40+/+; 3 PBS-treated Bhlhe40-/-; 7 IL-4c-treated Bhlhe40+/+; 6 IL-4c-treated 
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Bhlhe40-/-). (H) Flow cytometry of Bhlhe40GFP transgene reporter expression in thioglycollate 
(Thio)-elicited macrophages from Bhlhe40GFP+ and Bhlhe40GFP- mice treated with Thio or 
Thio and IL-4c (1 experiment, n=2 Thio-treated Bhlhe40GFP+; 3 Thio and IL-4c-treated 
Bhlhe40GFP+; 1 Thio-treated Bhlhe40GFP-). (I) Flow cytometry of BrdU incorporation by Thio-
elicited macrophages from Bhlhe40+/+ and Bhlhe40-/- mice treated with Thio and IL-4c 
(representative of 2 experiments, n=6/group). (J) Frequency of BrdU+ LPMs and Thio-elicited 
macrophages from Bhlhe40+/+ and Bhlhe40-/- mice treated with PBS, IL-4c, Thio, or Thio and 
IL-4c (pooled from 2 experiments, n=3 PBS-treated Bhlhe40+/+, 4 PBS-treated Bhlhe40-/-, 4 
IL-4c-treated Bhlhe40+/+, 5 IL-4c-treated Bhlhe40-/-, 2 Thio-treated Bhlhe40+/+, 4 Thio-treated 
Bhlhe40-/-, Thio and IL-4c-treated as in (I)). Data are mean ± s.e.m. *P ≤ 0.05; **P < 0.01; 




Figure 2.9. Loss of Bhlhe40 causes morphological changes in in vivo IL-4c-stimulated 
peritoneal macrophages. (A, B) Transmission electron microscopy (TEM) images of LPMs 
from naïve (A) and IL-4c-treated (B) Bhlhe40+/+ and Bhlhe40-/- mice (representative of 2 
experiments, n=2 mice (45-50 images)/group). Scale bar, 2 μm. (C-H) Cellular cross-sectional 
area (C), endoplasmic reticulum (ER) cross-sectional extent (D), ER luminal width (E), vesicle 
cross-sectional area (F), nucleoli/cross-section (G), mitochondria/cross-section (H) of LPMs as 
in (A, B) (pooled from 2 experiments, n=2 mice/group [17-60 cells analyzed]). Data are mean ± 
s.e.m. *P ≤ 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001, significance calculated with an 






Figure 2.10. Bhlhe40 expression is tightly regulated in resident macrophages. (A) Flow 
cytometry of Bhlhe40GFP transgene reporter expression in LPMs, SPMs, red pulp macrophages, 
Kupffer cells, kidney macrophages, and AMs from Bhlhe40GFP+ and Bhlhe40GFP- mice after PBS 
or IL-4c treatment (representative of 1-2 experiments, n=3 PBS-treated Bhlhe40GFP+, 1 PBS-
treated Bhlhe40GFP-, 5 IL-4c-treated Bhlhe40GFP+, 3 IL-4c-treated Bhlhe40GFP-). (B) Numbers of 
LPMs, red pulp macrophages, Kupffer cells, and AMs from Bhlhe40+/+ and Bhlhe40-/- mice 
treated with PBS or IL-4c (pooled from 2 experiments, n=4 PBS-treated Bhlhe40+/+, 3 PBS-
treated Bhlhe40-/-, 8 IL-4c-treated Bhlhe40+/+, 7 IL-4c-treated Bhlhe40-/-). (C-E) Flow cytometry 
of BrdU incorporation by red pulp macrophages (C), Kupffer cells (D), and AMs (E) from 
Bhlhe40+/+ and Bhlhe40-/- mice treated with PBS or IL-4c as in Fig. 5G. Data are mean ± s.e.m. 
*P ≤0.05, significance calculated with an unpaired two-sided Student’s t-test. 
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Figure 2.11. Bhlhe40 is required for normal proliferation of thioglycollate-elicited 
macrophages during type 2 immunity. (A) Flow cytometry of BrdU incorporation by LPMs 
and Thio-elicited macrophages from Bhlhe40+/+ and Bhlhe40-/- mice treated with PBS, IL-4c, 
thioglycollate (Thio), or Thio and IL-4c as in Fig. 5J. (B, C) Frequency of pHH3+ LPMs and 
Thio-elicited macrophages (B) (pooled from 2 experiments, n=3 PBS-treated Bhlhe40+/+; 4 PBS-
treated Bhlhe40-/-; 4 IL-4c-treated and Thio-treated Bhlhe40+/+ and Bhlhe40-/-; 6 Thio and IL-4c-
treated Bhlhe40+/+ and Bhlhe40-/-) and RELMα+ LPMs and Thio-elicited macrophages (C) 
(pooled as in (B)) from Bhlhe40+/+ and Bhlhe40-/- mice treated with PBS, IL-4c, thioglycollate 
(Thio), or Thio and IL-4c. Data are mean ± s.e.m. *P ≤ 0.05; ***P < 0.001, significance 
calculated with an unpaired two-sided Student’s t-test. 
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Figure 2.12. Bhlhe40 is required for LPM proliferation in response to H. polygyrus. (A) 
Flow cytometry of peritoneal macrophage subsets from Bhlhe40+/+ and Bhlhe40-/- mice 
infected with H. polygyrus (representative of 4 experiments, n=15 Bhlhe40+/+, 14 Bhlhe40-/-). 
(B) Numbers of LPMs from Bhlhe40+/+, Bhlhe40-/-, LysM-Cre- Bhlhe40fl/fl, and LysM-Cre+ 
Bhlhe40fl/fl mice mock- or H.polygyrus-infected as in (A) (pooled from 3 experiments, n=6 
mock-infected Bhlhe40+/+; 4 mock-infected Bhlhe40-/-; H. polygyrus-infected as in (A) for 
Bhlhe40+/+ and Bhlhe40-/-; 3 mock-infected LysM-Cre- Bhlhe40fl/fl and LysM-Cre+ Bhlhe40fl/fl; 
12 H. polygyrus-infected LysM-Cre- Bhlhe40fl/fl and LysM-Cre+ Bhlhe40fl/f). (C, D) Frequency 
of BrdU+ LPMs (C) (pooled from 3 experiments, n=4 mock-infected Bhlhe40+/+ and Bhlhe40-
/-; 14 H. polygyrus-infected Bhlhe40+/+; 12 H. polygyrus-infected Bhlhe40-/-; 3 mock-infected 
LysM-Cre- Bhlhe40fl/fl and LysM-Cre+ Bhlhe40fl/fl; 12 H. polygyrus-infected LysM-Cre- 
Bhlhe40fl/fl and LysM-Cre+ Bhlhe40fl/fl) and pHH3+ LPMs (D) (pooled from 3 experiments, 
n=6 mock-infected Bhlhe40+/+; 4 mock-infected Bhlhe40-/-; 15 H. polygyrus-infected 
Bhlhe40+/+; 14 H. polygyrus-infected Bhlhe40-/-; 3 mock-infected LysM-Cre- Bhlhe40fl/fl and 
LysM-Cre+ Bhlhe40fl/fl; 12 H. polygyrus-infected LysM-Cre- Bhlhe40fl/fl and LysM-Cre+ 
Bhlhe40fl/fl) from Bhlhe40+/+, Bhlhe40-/-, LysM-Cre- Bhlhe40fl/fl, and LysM-Cre+ Bhlhe40fl/fl 
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mice mock- or H. polygyrus-infected. (E) Proportion of LPMs in each phase of the cell cycle 
from Bhlhe40+/+ and Bhlhe40-/- mice mock- or H. polygyrus-infected (pooled from 2 
experiments, n=3 mock-infected Bhlhe40+/+, 2 mock-infected Bhlhe40-/-, 7 H. polygyrus-
infected Bhlhe40+/+, 6 H. polygyrus-infected Bhlhe40-/-). (F) Frequency of 7-AAD+ LPMs 
from Bhlhe40+/+, Bhlhe40-/-, LysM-Cre- Bhlhe40fl/fl, and LysM-Cre+ Bhlhe40fl/fl mice mock- or 
H. polygyrus-infected (pooled from 3 experiments, n=4 mock-infected Bhlhe40+/+; 3 mock-
infected Bhlhe40-/-; 12 H. polygyrus-infected Bhlhe40+/+ and Bhlhe40-/-; 3 mock-infected 
LysM-Cre- Bhlhe40fl/fl and LysM-Cre+ Bhlhe40fl/fl; 11 H. polygyrus-infected LysM-Cre- 
Bhlhe40fl/fl and LysM-Cre+ Bhlhe40fl/fl). Data are mean ± s.e.m. *P ≤ 0.05; **P < 0.01; ***P 




Figure 2.13. Bhlhe40 regulates gene expression to modulate proliferation, but not 
alternative activation, in LPMs during type 2 immunity. (A) Gene expression microarray 
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data were analyzed for genes differentially expressed by ≥2-fold in LPMs from Bhlhe40+/+, 
Bhlhe40-/-, and LysM-Cre+ Bhlhe40fl/fl mice treated with IL-4c. (B-D) Gene expression 
microarray data were analyzed for shared and unique Bhlhe40-dependent genes (≥2-fold 
differentially expressed, depicted as a Venn diagram) (B), shared Bhlhe40-dependent genes 
(C), and expression of the LPM alternative activation signature (D) in LPMs from Bhlhe40+/+, 
Bhlhe40-/-, and LysM-Cre+ Bhlhe40fl/fl mice unstimulated or treated with IL-4c. (E) qRT-PCR 
of Maf and Mafb expression relative to Hprt in Bhlhe40+/+ and Bhlhe40-/- LPMs from mice 
treated with IL-4c (pooled from 3 experiments, n=7 Bhlhe40+/+, 6 Bhlhe40-/-). (F, G) GSEA of 
gene expression microarray data for representative Hallmark (F) and C5 gene sets (G) 
enriched in Bhlhe40+/+ vs. Bhlhe40-/- LPMs from IL-4c-treated mice. NES, normalized 
enrichment score. FWER, family-wise error rate. (H, I) MSigDB C5 gene set enrichment was 
analyzed using the lists of genes expressed at ≥1.5-fold in Bhlhe40+/+ vs. Bhlhe40-/- (H) or 
Bhlhe40-/- vs. Bhlhe40+/+ LPMs from IL-4c-treated mice (I). Microarray data from naïve 
LPMs (n=3/group, reanalyzed from Fig. 3) and in vivo IL-4c-stimulated LPMs (n=2/group) 
are from single separate experiments. Data are mean ± s.e.m. ***P < 0.001; ****P < 0.0001, 




Figure 2.14. Bhlhe40 directly regulates gene transcription in LPMs. (A) Gene expression 
microarray data were analyzed for expression of genes encoding selective regulators of LPM 
proliferation (Myo18a and C1q) in LPMs from Bhlhe40+/+, Bhlhe40-/-, and LysM-Cre+ Bhlhe40fl/fl 
mice unstimulated or treated with IL-4c. (B-D) Tracings of Bhlhe40 binding, PU.1 binding, and 
vertebrate conservation at the Il10 (B), Ccl2 (C), and Plac8 (D) loci. (E) Bhlhe40-bound, 
Bhlhe40-dependent genes (≥2-fold differentially expressed in Bhlhe40+/+ and Bhlhe40-/- LPMs) 
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in LPMs from naïve mice and Bhlhe40-bound, Bhlhe40-dependent genes (≥2-fold differentially 
expressed in Bhlhe40+/+ and Bhlhe40-/- LPMs) in LPMs from IL-4c-treated mice, as in Fig. 8I. 
Underlined genes are highlighted elsewhere in this study. (F-H) Tracings of Bhlhe40 binding, 
PU.1 binding, and vertebrate conservation at the Maf (distal) (F), Mafb (G), and Mafb (distal) 
(H) loci. LPM Bhlhe40 ChIP-seq data (n=1/group), microarray data from naïve LPMs 
(n=3/group), and microarray data from IL-4c-stimulated LPMs (n=2/group) are from single 












Figure 2.15. Bhlhe40 directly regulates gene expression in LPMs in an activation state-
dependent manner. (A) Bhlhe40 ChIP-seq data were analyzed for consensus binding motifs 
in LPMs from naive (left) and IL-4c-treated mice (right). (B) Bhlhe40 ChIP-seq data were 
analyzed for locations of Bhlhe40 peaks in the genome in LPMs from naive (left) and IL-4c-
treated mice (right). UTR, untranslated region. (C) Tracings of Bhlhe40 binding, PU.1 binding, 
and vertebrate conservation at the Bhlhe40 locus. (D) Bhlhe40 ChIP-seq data were analyzed for 
shared and unique Bhlhe40 binding sites in LPMs from naive and IL-4c-treated mice 
(depicted as a Venn diagram). (E) Tracings of Bhlhe40 binding, PU.1 binding, and vertebrate 
conservation at the Clec10a locus. (F) Naïve LPM Bhlhe40 ChIP-seq data, in vivo IL-4c-
stimulated LPM Bhlhe40 ChIP-seq data, and naïve LPM PU.1 ChIP-seq data were analyzed 
for shared and unique Bhlhe40 and PU.1-bound genes between the three samples (depicted as 
a Venn diagram). (G) The proportion of Bhlhe40-bound, Bhlhe40-dependent genes (≥2-fold 
differentially expressed in Bhlhe40+/+ and Bhlhe40-/- LPMs) in LPMs from naïve mice and 
Bhlhe40-bound, Bhlhe40-dependent genes (≥2-fold differentially expressed in Bhlhe40+/+ and 
Bhlhe40-/- LPMs) in LPMs from IL-4c-treated mice. (H) Tracings of Bhlhe40 binding, PU.1 
binding, and vertebrate conservation at the Maf locus. (I) GSEA of gene expression microarray 
data for Bhlhe40-bound genes from LPMs from Bhlhe40+/+ and Bhlhe40-/- mice treated with IL-
4c for the C5 Cell Cycle Process gene set. NES, normalized enrichment score. FWER, family-
wise error rate. LPM Bhlhe40 ChIP-seq data (n=1/group) and microarray data from in vivo IL-
4c-stimulated LPMs (n=2/group) are from single separate experiments. LPM PU.1 ChIP-seq 




Figure 2.16. Bhlhe40 directly binds to cell cycle-related loci and is required to sustain 
normal gene expression. (A-D) The proportion of Bhlhe40-bound members of gene sets 
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enriched in Bhlhe40+/+ compared to Bhlhe40-/- LPMs from IL-4c-treated mice. Tracings of 
Bhlhe40 binding, PU.1 binding, and vertebrate conservation for a representative member of the 
core enrichment signature for each gene set is presented. Hallmark E2F Targets (A), Hallmark 
Myc Targets (v1) (B), C5 Chromosome Organization (C), and C5 Cell Cycle Process (D). (E-H) 
GSEA of expression of Bhlhe40-bound genes from gene expression microarray data from LPMs 
from Bhlhe40+/+ and Bhlhe40-/- mice treated with IL-4c for Hallmark E2F Targets (E), Hallmark 
Myc Targets v1 (F), C5 Chromosome Organization (G), and C5 Cell Cycle Process (H). C5 Cell 
Cycle Process is also presented in Fig. 8I. NES, normalized enrichment score. FWER, family-
wise error rate. LPM Bhlhe40 ChIP-seq data (n=1/group) and microarray data (n=2/group) are 














Chapter 3: Bhlhe40 is required for protective TH2 cell 
responses to helminth infection 
 
The contents of this chapter have been modified from the following preprint article (submitted): 
 
Deficiency in Bhlhe40 impairs resistance to H. polygyrus bakeri and reveals novel Csf2rb-
dependent regulation of anti-helminth immunity 
 
NN Jarjour, TR Bradstreet, EA Schwarzkopf, ME Cook, C-W Lai, SC-C Huang, R Taneja, TS 




The cytokines GM-CSF and IL-5 are thought to possess largely divergent functions despite a 
shared dependence on the common beta (βC) chain to initiate signaling. Although IL-5 is part of 
the core type 2 cytokine signature and is required for protection against some helminths, it is 
dispensable for immunity to others, such as Heligmosomoides polygyrus bakeri (H. polygyrus). 
Whether this is due to compensatory mechanisms is unclear. The transcription factor Bhlhe40 
has been shown to control GM-CSF production and is proposed to be a novel regulator of T 
helper type 2 cells. We have found that Bhlhe40 is required in T cells for a protective memory 
response to secondary H. polygyrus infection. H. polygyrus rechallenge elicited dramatic 
Bhlhe40-dependent changes in gene and cytokine expression by lamina propria CD4+ T cells and 
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in vitro-polarized TH2 cells, including induction of GM-CSF and maximal production of type 2 
cytokines including IL-5. βC chain-deficient, but not GM-CSF-deficient, mice rechallenged with 
H. polygyrus had severely impaired protective immunity. Our results demonstrate that Bhlhe40 is 
an essential regulator of TH2 cell immunity during helminth infection and reveal unexpected 




Helminthic worms are parasites of eukaryotic organisms which manipulate the immune system 
to establish chronic infections in diverse sites, often resulting in significant tissue damage (Allen 
and Sutherland, 2014; Maizels et al., 2018; Patel et al., 2009; Sorobetea et al., 2018). A 
stereotypical helminth infection results in production of alarmins including IL-25, IL-33, and 
thymic stromal lymphopoietin (TSLP), which in turn stimulate the development of type 2 
immunity characterized by production of IL-4, IL-5, and IL-13 (Allen and Sutherland, 2014; 
Maizels et al., 2018; Sorobetea et al., 2018). The helminth Heligmosomoides polygyrus bakeri 
(hereafter H. polygyrus) is a natural pathogen of mice and has been frequently employed as a 
model helminth infection (Camberis et al., 2003; Maizels et al., 2018; Patel et al., 2009; 
Sorobetea et al., 2018). Several cytokines contribute to protective immunity against H. 
polygyrus, including IL-4 and IL-25, while IL-5, IL-33, and TSLP are considered dispensable for 
control of this infection (Massacand et al., 2009; Pei et al., 2016; Urban et al., 1991; Zaiss et al., 
2013). 
 However, in many instances of type 2 immunity, IL-5 plays a crucial role (Bagnasco et 
al., 2017; Roufosse, 2018), including in some helminth infections (Allen and Sutherland, 2014; 
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Maizels et al., 2004; Sorobetea et al., 2018). Controversy previously existed as to whether IL-5 
was protective against helminths, but it is now appreciated that deficiency in IL-5 only affects 
immunity to select parasites and sometimes in a life cycle stage-dependent manner (Allen and 
Sutherland, 2014; Maizels et al., 2004). IL-5 binds to the unique IL-5Rα chain paired with the 
common beta (βC) chain, which is shared with the receptors for GM-CSF and IL-3 (Dougan et 
al., 2019; Robb et al., 1995). This raises the possibility that redundancy within this cytokine 
family could render individual members dispensable during helminth infection. While IL-3 
signaling is maintained in mice in the absence of the βC chain (Csf2rb) through a unique beta 
chain (βIL3, Csf2rb2), GM-CSF and IL-5 signaling is abrogated in Csf2rb
-/- mice (Dougan et al., 
2019; Robb et al., 1995). Despite absolute dependence on this shared receptor chain, which is 
largely responsible for downstream signaling (Dougan et al., 2019), known roles for IL-5 and 
GM-CSF are divergent. GM-CSF has been proposed to be a central regulator of inflammation 
driven by TH1 and TH17 cells and affects both autoimmunity and infection (Becher et al., 2016; 
Croxford et al., 2015; Deepe et al., 1999; Gonzalez-Juarrero et al., 2005; Hirata et al., 2010; 
LeVine et al., 1999; Mandujano et al., 1995; Paine et al., 2000; Zhan et al., 1998). GM-CSF also 
contributes to pathological TH2 responses to allergens (Cates et al., 2004; Sheih et al., 2017; 
Yamashita et al., 2002). However, little is known regarding GM-CSF during type 2 infections, 
though it is thought to be dispensable during infection with the helminth Nippostrongylus 
brasiliensis (Shim et al., 2012). 
 The transcription factor Bhlhe40 functions in B cells, NKT cells, T cells, and tissue-
resident macrophages (Camponeschi et al., 2018; Huynh et al., 2018; Jarjour et al., 2019a; Kanda 
et al., 2016; Kreslavsky et al., 2017; Lin et al., 2016; Lin et al., 2014; Martínez-Llordella et al., 
2013; Seimiya et al., 2004; Yu et al., 2018). We and others have described a crucial role for 
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Bhlhe40 as a modulator of TH1 and TH17 cell cytokine production in infection and 
autoimmunity, particularly by controlling GM-CSF and IL-10 production (Huynh et al., 2018; 
Lin et al., 2016; Lin et al., 2014; Martínez-Llordella et al., 2013; Yasuda et al., 2019; Yu et al., 
2018). Recent studies of in vitro-polarized TH2 cells (Henriksson et al., 2019) and house dust 
mite (HDM)-elicited airway TH2 cells (Tibbit et al., 2019) have identified Bhlhe40 as a potential 
regulator of this cell type in vivo. We have also recently described a role for Bhlhe40 in large 
peritoneal macrophages (LPMs) during type 2 immunity (Jarjour et al., 2019a). Taken together, 
these data suggest that Bhlhe40 may regulate type 2 infections, possibly by controlling cytokine 
production from T cells or via a myeloid cell-intrinsic role. 
 Herein, we have found that Bhlhe40 and the βC
 chain are essential to protective memory 
to secondary H. polygyrus infection. Bhlhe40-/- mice exhibited severe defects during rechallenge 
infection with H. polygyrus and altered intestinal pathology, which were recapitulated in Cd4-
Cre+ Bhlhe40fl/fl, but not LysM-Cre+ Bhlhe40fl/fl mice. We defined a helminth-induced gene 
signature in lamina propria CD4+ T cells, which was disrupted in the absence of Bhlhe40. In 
vitro-polarized TH2 cells and H. polygyrus-elicited CD4
+ T cells from the small intestine lamina 
propria exhibited Bhlhe40-dependent production of GM-CSF, and Bhlhe40-deficient CD4+ T 
cells also exhibited reduced production of IL-5 and other cytokines. Secondary infection of 
Csf2rb-/-, but not Csf2-/-, mice resulted in severely impaired protective immunity and altered 
intestinal pathology. Overall, Bhlhe40 serves as a pivotal regulator of the TH2 cell transcriptional 
response to helminth infection, in part by modulating GM-CSF and IL-5 production, and reveals 





Bhlhe40 is required for control of H. polygyrus rechallenge 
Primary oral challenge of C57BL/6 mice with H. polygyrus results in chronic infection, but 
rechallenge evokes a protective recall response which limits infection (Filbey et al., 2014). To 
assess whether Bhlhe40 was required for immunity to H. polygyrus, we challenged C57BL/6 
Bhlhe40+/+ and Bhlhe40-/- mice with infective H. polygyrus larvae (L3), cured them by treatment 
with pyrantel pamoate, and rechallenged them with infective L3. While Bhlhe40+/+ and Bhlhe40-/- 
mice exhibited similar parasite fecal egg burdens during primary infection, Bhlhe40-/- mice had a 
much higher egg burden during secondary infection as compared to Bhlhe40+/+ mice (Fig. 3.1A). 
While there was a trend towards increased adult worm burden in Bhlhe40-/- as compared to 
Bhlhe40+/+ mice after rechallenge (Fig. 3.1B), this did not reach statistical significance, 
indicating that their increased egg burden was primarily due to increased worm fecundity. H. 
polygyrus-rechallenged Bhlhe40+/+ and Bhlhe40-/- mice had dramatically different pathology. 
Type 2 granulomas can form around developing parasites and have been correlated with 
protective immunity (Filbey et al., 2014). Small intestines from Bhlhe40+/+ mice exhibited many 
granulomas, while those from Bhlhe40-/- mice resembled healthy tissue (Fig. 3.1C, D). 
Histological analysis and immunostaining showed reduced immune infiltration and damage to 
the smooth muscle layer in H. polygyrus-rechallenged Bhlhe40-/- as compared to Bhlhe40+/+ mice 
(Fig. 3.1E, F). 
When we explored the cellular composition of the small intestine lamina propria (SILP) 
following H. polygyrus rechallenge of Bhlhe40+/+ mice by flow cytometry, we found both 
CD45+CD64+F4/80+MHC-II+Ly6C- resident macrophages (Bain et al., 2014; Scott et al., 2017) 
and another CD45+F4/80+CD64+MHC-IIloLy6Clo autofluorescent population, which we termed 
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granuloma-associated monocytes/macrophages (GMMs) (Fig. 3.2A, B). This latter population 
may correspond to previously described clodronate-sensitive alternatively activated macrophages 
seen by immunostaining during H. polygyrus infection (Anthony et al., 2006). SILP 
CD45+F4/80+CD64-CD11b+SSC-Ahi eosinophils were also significantly increased after 
secondary H. polygyrus infection (Fig. 3.2A, B and 3.3A). However, GMMs and eosinophils 
were greatly reduced in H. polygyrus-rechallenged Bhlhe40-/- as compared to Bhlhe40+/+ mice, in 
contrast to SILP CD3+ T cells (Fig. 3.2A, B and 3.3B). Because H. polygyrus infection is known 
to change the cellular composition of the peritoneal cavity (Allen and Sutherland, 2014; Mohrs et 
al., 2005; Steinfelder et al., 2017), we assessed accumulation of LPMs and peritoneal 
eosinophils, and found severe reductions in both populations in H. polygyrus-rechallenged 
Bhlhe40-/- as compared to Bhlhe40+/+ mice, as well as impaired LPM polarization as assessed by 
RELMα staining (Fig. 3.2C-E and 3.3C-E). In contrast, serum H. polygyrus-specific IgG1 titers 
were not affected by loss of Bhlhe40 (Fig. 3.3F). These data indicated impaired responses by 
multiple myeloid cell lineages to H. polygyrus rechallenge in Bhlhe40-/- mice. 
 
Bhlhe40 is required in T cells for normal immunity to H. polygyrus  
We next employed Cd4-Cre+ Bhlhe40fl/fl and LysM-Cre+ Bhlhe40fl/fl mice to address whether loss 
of Bhlhe40 specifically in T cells or myeloid cells recapitulated the phenotype of Bhlhe40-/- mice 
during secondary H. polygyrus infection. Cd4-Cre+ Bhlhe40fl/fl mice were severely impaired in 
controlling H. polygyrus rechallenge and lacked intestinal granulomas as compared to Cd4-Cre- 
Bhlhe40fl/fl mice (Fig. 3.4A, B). When we assessed the response of myeloid cells to secondary 
infection, we found that loss of Bhlhe40 selectively in T cells was sufficient to perturb both the 
SILP and peritoneal responses (Fig. 3.4C-F). In contrast, LysM-Cre+ Bhlhe40fl/fl mice were able 
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to control infection and formed intestinal granulomas comparably to LysM-Cre- Bhlhe40fl/fl mice 
(Fig. 3.4G, H). Therefore, Bhlhe40 expression was required in T cells to control secondary H. 
polygyrus infection, but was dispensable in LysM-expressing myeloid cells. 
 
Bhlhe40 is required for a normal CD4+ T cell transcriptional response to H. polygyrus  
We next asked whether loss of Bhlhe40 dysregulated CD4+ T cell gene expression in response to 
H. polygyrus rechallenge. To address this, we sorted CD4+ T cells from the SILP of naïve and 
rechallenged Bhlhe40+/+ and Bhlhe40-/- mice for gene expression microarrays. By comparing 
CD4+ T cells from naïve and H. polygyrus-rechallenged Bhlhe40+/+ mice, we defined a helminth-
induced signature which included transcripts for cytokines (including Areg, Il3, Il4, Il5, Il6, Il13, 
Csf1, Csf2, Lif, Tnf, Tnfsf11), cytokine receptors (including Il1rl1, Il1r2, Il17rb), and 
transcription factors (including Atf3, Bhlhe40, Gata3, Nfil3, Pparg, Rbpj, Vdr, and Zeb2) (Fig. 
3.5A and 3.6A). When we assessed Bhlhe40-dependent genes after H. polygyrus rechallenge, we 
found that a significant majority were part of the helminth-induced signature and that Bhlhe40-
dependent genes were distinct in CD4+ T cells from naïve and H. polygyrus-rechallenged mice 
(Fig. 3.5B, C and 3.6B, C). When we used gene set enrichment analysis (GSEA) to look for 
Bhlhe40-dependent gene modules, we noted that two of the most enriched sets in Bhlhe40+/+ as 
compared to Bhlhe40-/- CD4+ T cells after H. polygyrus rechallenge were “growth factor activity” 
and “cytokine activity,” reflecting altered expression of cytokine genes including Areg, Il5, Il6, 
Il13, Csf1, Csf2, and Lif, but not Il3, Il4, or Tnf (Fig. 3.5D, E). Furthermore, when we assessed 
differential expression of the lineage-specifying transcription factors of each T helper cell subset 
as well as a recently defined set of transcriptional regulators of in vitro-polarized TH2 cells 
(Henriksson et al., 2019), we observed reduced expression of Pparg in Bhlhe40-/- as compared to 
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Bhlhe40+/+ CD4+ T cells from H. polygyrus-rechallenged mice (2.4-fold reduced), but only subtle 
changes in other factors including Gata3 (1.4-fold reduced) (Fig. 3.5E). Bhlhe40 expression was 
markedly induced in mice experiencing secondary infection as compared to naïve mice (Fig. 
3.5E). Using Bhlhe40GFP bacterial artificial chromosome reporter mice (Lin et al., 2016), we 
observed a marked increase in SILP GFP+ CD4+ T cells after H. polygyrus rechallenge (Fig. 
3.5F). Taken together, these data showed that Bhlhe40 was induced by SILP CD4+ T cells in 
response to H. polygyrus rechallenge and was critical for their normal transcriptional program. 
 
Loss of Bhlhe40 impairs T cell cytokine production in response to H. polygyrus 
Next, we restimulated SILP cells from naïve and rechallenged Cd4-Cre- Bhlhe40fl/fl and Cd4-
Cre+ Bhlhe40fl/fl mice ex vivo with phorbol 12-myristate 13-acetate (PMA) and ionomycin to 
assess cytokine production. Rechallenge with H. polygyrus induced production of IL-4, IL-5, and 
IL-13 from Cd4-Cre- Bhlhe40fl/fl and Cd4-Cre+ Bhlhe40fl/fl CD4+ T cells; however, Bhlhe40 was 
required for normal frequencies of single- and multi-cytokine-producing cells, largely due to 
reductions in IL-5+ and IL-13+ CD4+ T cells (Fig. 3.7A-C). Because Csf2 was upregulated by H. 
polygyrus rechallenge in a Bhlhe40-dependent fashion, we also assessed GM-CSF and found that 
it was markedly induced by rechallenge (~35% of Cd4-Cre- Bhlhe40fl/fl CD4+ T cells) and that 
this required Bhlhe40 (~10% of Cd4-Cre+ Bhlhe40fl/fl CD4+ T cells) (Fig. 3.7D, E). TH2 cells 
disseminate widely in mice infected with H. polygyrus (Mohrs et al., 2005; Steinfelder et al., 
2017). CD4+ T cell cytokine responses in the peritoneal cavity and mesenteric lymph nodes from 
H. polygyrus-rechallenged Cd4-Cre- Bhlhe40fl/fl and Cd4-Cre+ Bhlhe40fl/fl mice were generally 
consistent with those in the SILP (Fig. 3.8). To assess whether Bhlhe40 was also required for 
normal cytokine production by a pure population of TH2 cells, we differentiated naïve splenic 
84 
 
CD4+ T cells into TH2 cells and restimulated them to assess cytokine production. We found that 
Bhlhe40 was essential for production of GM-CSF and that loss of Bhlhe40 also impaired in vitro 
production of type 2 cytokines (Fig. 3.9). Therefore, these data indicated that Bhlhe40 is required 
in vitro and in vivo for normal TH2 cell function. 
As Bhlhe40 is a known repressor of IL-10 (Huynh et al., 2018; Lin et al., 2016; Lin et al., 
2014; Yu et al., 2018), we also assessed IL-10 production from SILP CD4+ T cells. Indeed, SILP 
CD4+ T cells lacking Bhlhe40 produced significantly higher levels of IL-10 after H. polygyrus 
rechallenge (Fig. 3.10A). Nevertheless, genetic deletion of IL-10 in Bhlhe40-/- Il10-/- mice was 
not sufficient to restore control of infection or normal intestinal granulomatous pathology (Fig. 
3.10B, C). Collectively, these data demonstrated a key role for Bhlhe40 in CD4+ T cell cytokine 
responses to helminth infection, notably controlling production of the βC chain family cytokines 
IL-5 and GM-CSF. 
 
Loss of the βC chain impairs protective memory to H. polygyrus  
As protective memory responses to H. polygyrus rechallenge are unaffected by IL-5 blockade 
(Urban et al., 1991), we first asked whether loss of GM-CSF signaling was sufficient to impair 
control of a secondary infection with H. polygyrus. Genetic deletion of GM-CSF (Csf2-/- mice) 
did not result in severe defects in control of H. polygyrus infection as compared to Csf2+/+ mice 
(Fig. 3.11A-F). As IL-5 and GM-CSF were individually dispensable, we then rechallenged 
Csf2rb+/+ and Csf2rb-/- mice. Remarkably, Csf2rb-/- mice had a severe defect in control of H. 
polygyrus as compared to Csf2rb+/+ mice (Fig. 3.12A). Csf2rb-/- mice did not form intestinal 
granulomas or develop a normal SILP myeloid cell response to H. polygyrus rechallenge as 
compared to Csf2rb+/+ mice (Fig. 3.12B, C). Furthermore, loss of the βC chain resulted in defects 
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in peritoneal myeloid cell responses similar to those seen in Bhlhe40-/- and Cd4-Cre+ Bhlhe40fl/fl 
mice (Fig. 3.12D-F). To exclude a role for βC chain-dependent IL-3 signaling, we singly blocked 
GM-CSF or IL-5 signaling with neutralizing antibodies or blocked both cytokines together. 
Double, but not single, blockade resulted in severely impaired protective immunity (Fig. 3.11G, 
H). Taken together, these data indicated that IL-5 and GM-CSF were collectively, but not 
individually, critical to control of H. polygyrus rechallenge. 
 
3.4 Discussion 
We have demonstrated that protective memory responses against H. polygyrus are critically 
dependent on Bhlhe40 and the βC chain. Bhlhe40 is specifically required in CD4
+ T cells to 
promote a normal myeloid cell response to H. polygyrus by supporting expression of cytokine 
transcripts as well as other potential regulators of helminth infection, including Areg, Csf2, Il5, 
Il13, Nlrp3, and Pparg (Chen et al., 2017; Chenery et al., 2019; Zaiss et al., 2006). We have also 
described the CD4+ T cell transcriptome within the SILP during secondary H. polygyrus 
infection. These data provide unique insight into the CD4+ T cell global transcriptional response 
to helminths at the site of infection. We found that Bhlhe40 is a key regulator of TH2 cell 
cytokine production. Notably, GM-CSF and IL-5 were markedly stimulated by H. polygyrus 
rechallenge and this response was Bhlhe40-dependent. In light of these data, we assessed the 
importance of the βC chain during H. polygyrus rechallenge and found that it was critically 
required for protective immunity, despite control of secondary H. polygyrus infection during IL-
5 blockade (this manuscript and Urban et al., 1991), during GM-CSF blockade, and in Csf2-/- 
mice. These data support redundant roles for Bhlhe40-dependent βC chain-dependent cytokines 
in protective immunity to H. polygyrus. 
86 
 
When we compared differentially expressed transcripts between H. polygyrus-elicited 
and naive SILP CD4+ T cells, we found a remarkable similarity to the transcriptional profile of 
HDM-elicited airway TH2 cells (Bhlhe40, Cd200r1, Il6, Plac8, Igfbp7) (Tibbit et al., 2019), 
demonstrating significant conservation of the TH2 transcriptional program independent of tissue 
environment and stimulus. When we assessed whether Bhlhe40 was functionally required in T 
cells during type 2 immunity, we found that SILP CD4+ T cells activated by H. polygyrus 
rechallenge required Bhlhe40 for normal expression of many helminth-induced genes and to 
control helminth rechallenge. We therefore demonstrate for the first time that Bhlhe40 regulates 
in vivo TH2 cell responses, consistent with a recent screen for novel regulators of in vitro-
polarized TH2 cells that identified Bhlhe40 (Henriksson et al., 2019). Notably, Pparg expression 
was reduced in the absence of Bhlhe40, and as PPARγ is required for normal TH2 cell responses 
and protective immunity to H. polygyrus, this may indicate that some of the effects of Bhlhe40 
deficiency are indirect (Chen et al., 2017; Nobs et al., 2017). Our work and that of others has 
now established key roles for Bhlhe40 in TH1, TH2, and TH17 cells as a pivotal regulator of GM-
CSF, IL-10, and other cytokines (Huynh et al., 2018; Lin et al., 2016; Lin et al., 2014; Martínez-
Llordella et al., 2013; Yasuda et al., 2019; Yu et al., 2018). These data and a recent study on c-
Maf (Gabrysova et al., 2018) suggest that T cell production of many cytokines may be controlled 
by multi-lineage transcription factors in addition to lineage-restricted factors. In light of the 
critical role for Bhlhe40 in multiple CD4+ T cell subsets, clinical targeting of factors regulating 
Bhlhe40 may possess significant therapeutic potential. 
While GM-CSF and IL-5 have long been known to share common signaling through the 
βC chain, their described functions are largely distinct, with GM-CSF contributing to TH1 and 
TH17 cell-driven inflammation and IL-5 contributing to type 2 immunity (Bagnasco et al., 2017; 
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Becher et al., 2016; Codarri et al., 2011; Roufosse, 2018). We have demonstrated that protective 
memory to a helminth infection unaffected by IL-5 blockade and also insensitive to GM-CSF 
deficiency is nonetheless dependent on the combination of GM-CSF and IL-5 signaling through 
the βC chain. It remains to be determined how GM-CSF and IL-5 compensate for each other, 
whether by direct substitution or via effects on distinct arms of the type 2 response. While 
redundancy between βC chain family cytokines is not well described, it is known that these 
cytokines can regulate eosinophils in a complementary manner (Esnault and Kelly, 2016). Future 
studies should identify the targets of βC family cytokine signaling and establish whether GM-
CSF and IL-5 are collectively involved in protective immunity to other helminth infections. As 
βIL3 chain-dependent IL-3 signaling is preserved in Csf2rb
-/- mice (Dougan et al., 2019; Robb et 
al., 1995), it is also of interest to establish whether additionally blocking IL-3 results in a more 
severe defect in immunity to H. polygyrus than is observed in Csf2rb-/- mice. IL-3 regulates 
basophilia in response to H. polygyrus and basophils help control infection with this helminth 
(Herbst et al., 2012; Schwartz et al., 2014), suggesting that IL-3 is likely important for control of 
H. polygyrus infection. 
Our findings reveal novel transcriptional and cytokine regulation of the immune response 
to helminth infection, elucidating a critical function for Bhlhe40 during in vivo TH2 cell 
immunity and an unexpected role for βC chain-dependent signaling. Our data suggest that the 
importance of βC chain family cytokines may have been underestimated in type 2 diseases 
because of redundancy. Further studies are needed to elucidate whether compensation between 
βC chain family cytokines is a general theme of type 2 immunity and whether combinatorial 







C57BL/6 (Taconic and Jackson), Il10-/- (B6.129P2-Il10tm1Cgn/J, Jackson), Csf2-/- (B6.129S-
Csf2tm1Mlg/J, Jackson), Csf2rb-/- (B6.129S1-Csf2rbtm1Cgb/J, Jackson), Cd4-Cre (B6.Cg-Tg(Cd4-
cre)1Cwi/BfluJ, Jackson) and LysM-Cre (B6N.129P2(B6)-Lyz2tm1(cre)Ifo/J, Jackson) mice were 
obtained from the vendors listed. Bhlhe40-/- (10 generations backcrossed to the C57BL/6 
background) (Lin et al., 2014; Sun et al., 2001), Bhlhe40GFP+ (10 generations backcrossed to the 
C57BL/6 background) (Lin et al., 2016), and Bhlhe40fl/fl (Huynh et al., 2018) mice have been 
previously reported. All mice were maintained in our specific pathogen free animal facility. Sex-
matched littermates were used for experiments whenever possible. Experiments with Csf2-/- and 
Csf2rb-/- mice used cohoused, age-matched, sex-matched C57BL/6 controls bred in our animal 
facility or purchased from Jackson. All animal experiments were approved by the Animal 
Studies Committee of Washington University in St. Louis. 
 
Heligmosomoides polygyrus bakeri infections 
Infective Heligmosomoides polygyrus bakeri third-stage larvae (L3) were prepared as described 
(Camberis et al., 2003). For both primary and secondary infection, mice were orally gavaged 
with 200 L3 with a 20-gauge ball-tipped gavage needle. Female mice were used for experiments 
whenever possible. Fecal samples were collected at 8, 11, 14, and 21 days after primary and 
secondary infection and weighed. Eggs were counted by dissolution of feces in 5 ml water, 
followed by a 1:1 dilution with a saturated sodium chloride solution before loading into a 
McMaster counting chamber (Chalex LLC). For rechallenge experiments, mice were cleared of 
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infection by oral gavage with 2 mg of pyrantel pamoate (Columbia Laboratories) diluted in 
Dulbecco’s PBS on days 14 and 15 after primary infection and were rested for 3-4 weeks before 
reinfection. Blood was collected at day 21 post-rechallenge and allowed to clot for >1 hour 
before serum collection by centrifugation at 1,500 g for 15 minutes. Mice were sacrificed on day 
17 or 22 of secondary infection for assessment of cellular responses. Macroscopic granulomas 
present at day 22 of secondary infection that were visible to the naked eye were counted along 
the length of the intact intestines. Assessment of the intestinal worm burden was performed at 
day 17 or 22 of primary or secondary infection. Adult worms were collected by cutting the 
intestine open and into ~4 in sections, placing the tissue and contents into a metal filter on top of 
a 50 ml tube of PBS, and setting the tube in a 37 ⁰C water bath. Worms then actively migrated 
through the filter over several hours and sedimented. Worms were counted visually in petri 
dishes.  
 
In vivo antibody blockade 
Mice were infected, cleared, and rested as above. Immediately before reinfection, mice were 
injected i.p. with 300 µg of αGM-CSF (Leinco, G670, clone MP1-22E9), 300 ug of αIL-5 
(BioXCell, BE0198, clone TRFK5), and/or control polyclonal rat IgG (Sigma Aldrich, I4131) 
and were given the same dose i.p. every other day until sacrifice (Codarri et al., 2011). 
 
In vitro TH2 cell culture 
The EasySep mouse naïve CD4+ T cell isolation kit (Stemcell Technologies, 19765A) was 
used to isolate T cells from the spleens of untreated mice. Cells were cultured in complete 
Iscove’s modified Dulbecco’s media (cIMDM, with added 10 % FBS, L-glutamine, sodium 
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pyruvate, non-essential amino acids, penicillin/streptomycin, and β-mercaptoethanol) in flat-
bottom, tissue culture-treated 48 well plates with plate-bound anti-CD3 and anti-CD28. Plates 
were coated overnight with anti-CD3 antibody (BioXCell, 2 μg/mL, clone 145-2C11) and 
anti-CD28 antibody (BioLegend, 2 μg/ml, clone 37.51) before use. To polarize naïve T cells 
to TH2 cells, IL-4 (BioLegend, 10 ng/mL) and anti-IFN-γ (Leinco, 5 μg/mL, clone H22) were 
added at the start of culture. Cells were split at day 3, and on day 4 cells were stimulated for 
24 hours with plate-bound anti-CD3 and anti-CD28 (coated as above) for assessment of 
secreted cytokines in the supernatant by ELISA.  
 
Enzyme-linked immunosorbent assay (ELISA) 
Nunc Maxisorp plates were coated with capture antibodies (for cytokine ELISAs) or H. 
polygyrus lysate (for H. polygyrus-specific IgG1 ELISA) overnight. Wells were washed with 
PBS-Tween 20 (0.05%), and 1% BSA in PBS was added for one hour to block. After washing, 
culture supernatants (cytokine ELISAs) or serum (IgG1 ELISA) were added for 1-2 hours, 
except for the GM-CSF ELISA (overnight). After washing, cytokine-detection biotinylated 
antibodies or horseradish peroxidase (HRP)-conjugated anti-mouse IgG1 antibody were added 
for 1 hour, except for the GM-CSF ELISA (2 hours). For cytokine ELISAs, following another 
wash, streptavidin-conjugated horseradish peroxidase (HRP) was added for 1 hour. After 
washing, a 1:1 mixture of room temperature TMB A and B solutions (BD OptEIA) was added. 
The reaction was stopped with 1 M H3PO4. Samples were analyzed on an iMark microplate 
reader (BioRad). For cytokine ELISAs, standard curves were generated with purified cytokines. 
For the IgG1 ELISA, serum was diluted between 10-2 and 10-8 and the last well with an OD450 
above 0.100 represented the titer.  
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To generate H. polygyrus lysate, adult worms collected as above were washed repeatedly 
in PBS, and ground in a Dounce homogenizer in 1 mL of PBS. Debris was then pelleted by 
centrifugation at 16,000 g for 20 minutes at 4 ⁰C. The supernatant was passed through a 0.2 μm 
filter and stored at -80 ⁰C. Lysate was titrated for an ELISA with the serum of H. polygyrus-
rechallenged mice, and the greatest dilution of lysate (1:1000) which yielded maximal signal was 
used.  
 
Brightfield and epifluorescence microscopy 
The proximal 6 cm of the small intestine were formed into a swiss roll (Bialkowska et al., 2016) 
and were frozen in OCT media. 10 μm cryosections were cut using a Leica CM1950 cryostat. 
For hematoxylin and eosin staining, sections were fixed in 4% PFA, washed, and stained. For 
immunofluorescent staining, sections were fixed in acetone, washed, and blocked with CAS-
Block (Invitrogen). Staining was performed with Cy3-anti-α-smooth muscle actin (clone 1A4, 
Sigma) and AlexaFluor647-anti-F4/80 (clone BM8, BioLegend) diluted in CAS block, followed 
by washing. Sections were mounted with Abcam Fluoroshield Mounting Medium with DAPI. 
All images were captured with a Nikon Eclipse E800 microscope equipped with a 
MicroPublisher 5.0 RTV camera (QImaging) for brightfield microscopy and an EXi Blue camera 
(QImaging) for fluorescence microscopy using QCapture software (QImaging). Fluorescence 
images were merged and levelled in Adobe Photoshop. 
 
Leukocyte collection from tissues 
Peritoneal cells were collected from body cavities by lavage. Mesenteric lymph nodes and 
spleens were harvested into cIMDM, homogenized through a 70 μm filter, and washed. Isolation 
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of small intestine lamina propria cells was performed as described (Bando et al., 2018). In brief, 
4 cm of the proximal small intestine were excised, cleaned of fecal contents, and cut into 2-3 
pieces. The tissue was shaken twice in 1x HBSS (with added HEPES, 10% FBS, EDTA, and 
DTT) for 20 minutes to remove the epithelial layer. The tissue was then shaken at 220 rpm at 37 
⁰C for 1 hour in an Innova 4330 shaker (New Brunswick Scientific) with Collagenase IV (Sigma, 
C5138) in RPMI 1640 (with added 10% FBS, L-glutamine, penicillin/streptomycin, and 2-
mercaptoethanol). Cells were then pelleted by centrifugation and washed. 
All cells were passed through a 70 μm cell strainer before analysis. If necessary, tissues 
were treated with ACK lysis buffer to lyse red blood cells. Cells were counted with a 
hemocytometer using trypan blue. 
 
Flow cytometry 
Cell surface staining was conducted in PBS with 0.5% BSA and 2 mM EDTA (hereafter FACS 
buffer) with or without 0.02% sodium azide. In brief, cells were washed in FACS buffer, blocked 
with α-CD16/32 (clone 2.4G2, BioXCell) for 5-10 minutes at 4 ⁰C, stained for 20 minutes at 4 
⁰C, and washed with FACS buffer before flow cytometry. Flow cytometry was performed on 
LSRFortessa X20, FACSCanto II, and LSR II instruments (all BD). Analysis was performed 
with FlowJo software (Treestar).  
Gating of cell populations was as follows (all analysis pre-gated on FSC/SSC followed 
by a FSC-W/FSC-A singlet gate). SILP macrophages were gated as CD45+F4/80+CD64+MHC-
II+Ly6C-, while GMMs were gated as CD45+F4/80+CD64+MHC-IIloLy6Clo. SILP eosinophils 
were gated as CD45+F4/80+CD64-CD11b+SSC-Ahi, and this approach was validated in some 
experiments with Siglec-F staining. SILP CD3+ T cells were gated as CD45+F4/80-CD64-CD19-
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CD3+. SILP CD4+ T cells were gated as CD19-F4/80-TCRβ+CD4+CD8-. LPMs were gated as 
CD115+CD11b+ICAM2+MHC-IIlo. Peritoneal eosinophils were gated as Siglec-F+ICAM2-. 
Peritoneal CD4+ T cells were gated as ICAM2-TCRβ+CD4+CD8-. Mesenteric lymph node CD4+ 
T cells were gated as CD19-TCRβ+CD4+CD8-. 
 
Intracellular staining for flow cytometry 
For intracellular cytokine staining of T cells, total SILP, peritoneal, and mesenteric lymph node 
cells were cultured at 0.5-1 million cells/well in a 96 well V-bottom non-tissue culture-treated 
plate for 3-4 hours at 37 °C with 8% CO2 in the presence of PMA (50 ng/ml), ionomycin (1 μM), 
and brefeldin A (1 μg/ml) in cIMDM. Cells were then surface stained and fixed with 4% 
paraformaldehyde (PFA). Cells were then washed with FACS buffer and stored overnight. To 
permeabilize the cells, samples were washed with 1x Perm/Wash buffer (BD, 554714) and 
stained for 20 minutes at 4 ⁰C, followed by washing in 1x Perm/Wash buffer and FACS buffer 
before flow cytometry. 
For RELMα staining, the BioLegend True-Nuclear Transcription Factor Buffer set 
(424401) was used. After surface staining, cells were fixed with 1x Fix Concentrate buffer in Fix 
Diluent for 30 minutes at 4 ⁰C. Cells were then washed with FACS buffer and stored overnight. 
Samples were washed with 1x Perm buffer diluted in water for permeabilization. After blocking 
with 2% rat serum, samples were stained for 1 hour at RT with anti-RELMα antibody followed 
by washing in 1x Perm buffer, staining with secondary antibody for 20 min at 4 ⁰C, washing in 





Singlet F4/80- TCRβ+ CD4+ CD8- SILP cells were sorted from naïve and H. polygyrus-
rechallenged mice using a FACSAria II (BD) into FBS, followed by lysis and RNA purification 
using the E.Z.N.A. MicroElute Total RNA kit (Omega Bio-Tek). RNA was submitted to the 
Genome Technology Access core at Washington University for cDNA synthesis (NuGen Pico 
SL) followed by analysis on the Affymetrix Mouse Gene 1.0 ST microarray platform. Data were 
analyzed with the DNASTAR ArrayStar program. All CEL files were normalized together. 
Genes with an expression value of >5 (in log 2 scale) in at least one replicate were considered 
expressed. For generation of lists of differentially expressed genes at a ≥2-fold differential 
expression cutoff between groups, p-value significance of ≤0.01 by the moderated t-test was also 
required. Morpheus was used to generate heatmaps (software.broadinstitute.org/morpheus/). The 
Venn Diagram Plotter tool (Pacific Northwest National Laboratories, omics.pnl.gov) was used to 
generate Venn diagrams. Multiple differentially expressed probe sets representing a single gene 
were presented in heat maps, but only unique genes were counted in Venn diagrams. To assess 
gene set enrichment, the GSEA software from the Broad Institute was used to analyze all 
expressed genes for enrichment of C5 database gene sets (Subramanian et al., 2005). 
 
Quantification and statistical analysis 
All data are from at least two independent experiments, unless otherwise indicated. Data were 
analyzed by unpaired two-tailed Student’s t-tests (Prism 7; GraphPad Software, Inc.) with p ≤ 
0.05 considered significant. For relevant comparisons where no p-value is shown, the p-value 
was > 0.05. The NES score calculated by the GSEA software was used to account for set size 
effects when determining enrichment of gene sets. The GSEA-calculated FWER p value was 
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used as a conservative measure of significance. Horizontal bars represent the mean and error bars 















Figure 3.1. Bhlhe40 is required for a protective recall response to H. polygyrus. (A-C) H. 
polygyrus-infected Bhlhe40+/+ and Bhlhe40-/- mice were analyzed for (A) quantitation of H. 
polygyrus eggs/gram feces over time during secondary infection, (B) quantitation of adult 
worms recovered from the intestines of mice experiencing primary or secondary infection, and 
(C) small intestine morphology after secondary infection. Arrows point to granulomas. Scale 
bar, 1 cm. (D) Quantitation of intestinal granulomas. (E, F) H. polygyrus-rechallenged 
Bhlhe40+/+ and Bhlhe40-/- mice were analyzed histologically on adjacent sections by (E) 
hematoxylin and eosin staining and (F) immunostaining for F4/80, α-SMA, and DAPI 
performed on swiss rolls of the proximal small intestine (2 representative lesions from each 
genotype). G, granuloma. M, muscle layers. P, peritoneal space. V, villi. Scale bar, 200 μm.  
Data are representative of at least 3 independent experiments (C, E, F) or are pooled from at 
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least 3 independent experiments (A, B, D). Data are mean ± s.e.m. Significance calculated 





















Figure 3.2. Bhlhe40 is required for normal myeloid cell responses to H. polygyrus 
rechallenge. (A, B) Naïve and H. polygyrus-rechallenged Bhlhe40+/+ and Bhlhe40-/- mice were 
analyzed by flow cytometry for (A) SILP myeloid cells and (B) quantitation as in (A). (C-E) 
Naïve and H. polygyrus-rechallenged Bhlhe40+/+ and Bhlhe40-/- mice were analyzed by flow 
cytometry for quantitation of (C) peritoneal eosinophils, (D) LPMs, and (E) the frequency of 
RELMα+ LPMs. Data are representative of at least 3 independent experiments (A) or are 
pooled from at least 3 independent experiments (B-E). Data are mean ± s.e.m. Significance 




Figure 3.3. Loss of Bhlhe40 dysregulates myeloid cell responses to H. polygyrus 
rechallenge. (A, B) Naïve and H. polygyrus-rechallenged Bhlhe40+/+ and Bhlhe40-/- mice were 
analyzed by flow cytometry for (A) SILP eosinophils and (B) quantitation of SILP CD3+ T 
cells. (C-E) Naïve and H. polygyrus-rechallenged Bhlhe40+/+ and Bhlhe40-/- mice were 
analyzed by flow cytometry for (C) peritoneal eosinophils, (D) LPMs, and (E) RELMα-
expressing LPMs. (F) Naïve and H. polygyrus-rechallenged Bhlhe40+/+ and Bhlhe40-/- mice 
were analyzed for serum anti-H. polygyrus IgG1 titers. Data are representative of at least three 
independent experiments (A, C-E) or are pooled from at least 3 independent experiments (B) 
or 2 independent experiments (F). Data are mean ± s.e.m. Significance calculated with an 





Figure 3.4. Bhlhe40 is required in T cells for a normal memory response to H. polygyrus. 
(A) H. polygyrus-rechallenged Cd4-Cre- Bhlhe40fl/fl and Cd4-Cre+ Bhlhe40fl/fl mice were 
analyzed for quantitation of H. polygyrus eggs/gram feces over time. (B) Naïve and H. 
polygyrus-rechallenged Cd4-Cre- Bhlhe40fl/fl and Cd4-Cre+ Bhlhe40fl/fl mice were analyzed for 
quantitation of intestinal granulomas. (C-F) Naïve and H. polygyrus-rechallenged Cd4-Cre- 
Bhlhe40fl/fl and Cd4-Cre+ Bhlhe40fl/fl mice were analyzed by flow cytometry for quantitation of 
(C) SILP myeloid cells, (D) peritoneal eosinophils, (E) LPMs, and (F) the frequency of 
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RELMα+ LPMs. (G) H. polygyrus-rechallenged LysM-Cre- Bhlhe40fl/fl and LysM-Cre+ 
Bhlhe40fl/fl mice were analyzed for quantitation of H. polygyrus eggs/gram feces over time. 
(H) Naïve and H. polygyrus-rechallenged LysM-Cre- Bhlhe40fl/fl and LysM-Cre+ Bhlhe40fl/fl 
mice were analyzed for quantitation of intestinal granulomas. Data are pooled from 3 
independent experiments (A-F) or 2 independent experiments (G, H). Data are mean ± s.e.m. 




Figure 3.5. Loss of Bhlhe40 dysregulates the CD4+ T cell transcriptional response to H. 
polygyrus rechallenge. (A, B) Gene expression microarray data were analyzed for the 100 most 
differentially expressed probe sets in SILP CD4+ T cells from (A) naïve and H. polygyrus-
rechallenged Bhlhe40+/+ mice and (B) H. polygyrus-rechallenged Bhlhe40+/+ and Bhlhe40-/- 
mice. (C) Gene expression microarray data were analyzed for shared and unique Bhlhe40-
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dependent genes (≥2-fold differentially expressed between SILP CD4+ T cells from H. 
polygyrus-rechallenged Bhlhe40+/+ and Bhlhe40-/- mice) with the helminth-induced signature 
(≥2-fold differentially expressed between SILP CD4+ T cells from naïve and H. polygyrus-
rechallenged Bhlhe40+/+ mice), depicted as a Venn diagram. (D) GSEA of gene expression 
microarray data for selected C5 gene sets enriched in Bhlhe40+/+ versus Bhlhe40-/- SILP CD4+ T 
cells from H. polygyrus-rechallenged mice. NES, normalized enrichment score. FWER, family-
wise error rate. (E) Gene expression microarray data were analyzed for (left) expression of 
cytokines induced by H. polygyrus rechallenge and (right) expression of TH2 and T helper cell 
lineage-specifying transcription factors in SILP CD4+ T cells from naïve and H. polygyrus-
rechallenged Bhlhe40+/+ and Bhlhe40-/- mice. TF, transcription factor. (F) Flow cytometry of 
Bhlhe40GFP transgene reporter expression in SILP CD4+ T cells from Bhlhe40GFP+ mice. Data in 







Figure 3.6. Bhlhe40 regulates distinct gene sets in CD4+ T cells from naïve and H. 
polygyrus-rechallenged mice. (A) Gene expression microarray data were analyzed for genes 
induced by ≥2-fold in SILP CD4+ T cells from H. polygyrus-rechallenged as compared to 
naïve Bhlhe40+/+ mice. (B) Gene expression microarray data were analyzed for shared and 
unique Bhlhe40-dependent genes (≥2-fold differentially expressed) in SILP CD4+ T cells from 
naïve or H. polygyrus-rechallenged Bhlhe40+/+ and Bhlhe40-/- mice, depicted as a Venn diagram. 
(C) Gene expression microarray data were analyzed for genes differentially expressed by ≥2-
fold in SILP CD4+ T cells from naïve Bhlhe40+/+ and Bhlhe40-/- mice. Microarray data are from 





Figure 3.7. Bhlhe40 is required for normal CD4+ T cell production of βC chain-dependent 
cytokines. (A-C) Naïve and H. polygyrus-rechallenged Cd4-Cre- Bhlhe40fl/fl and Cd4-Cre+ 
Bhlhe40fl/fl mice were analyzed by flow cytometry for (A) IL-4-, IL-5-, and IL-13-producing 
CD4+ T cells, (B) quantitation of the frequency of IL-4+, IL-5+, and IL-13+ CD4+ T cells, and 
(C) quantitation of the frequency of CD4+ T cells producing one or more cytokines after in 
vitro PMA/ionomycin stimulation of SILP cells. (D, E) Naïve and H. polygyrus-rechallenged 
Cd4-Cre- Bhlhe40fl/fl and Cd4-Cre+ Bhlhe40fl/fl mice were analyzed by flow cytometry for (D) 
GM-CSF-producing CD4+ T cells and (E) quantitation as in (D) after in vitro PMA/ionomycin 
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stimulation of SILP cells. Data are representative of 2 independent experiments (A, D) or are 
pooled from 2 independent experiments (B, C, E). Data are mean ± s.e.m. Significance 













Figure 3.8. Bhlhe40 is required in T cells for normal cytokine production during H. 
polygyrus rechallenge. (A and B) Naïve and H. polygyrus-rechallenged Cd4-Cre- Bhlhe40fl/fl 
and Cd4-Cre+ Bhlhe40fl/fl mice were analyzed by flow cytometry for quantitation of the 
frequency of IL-4+, IL-5+, IL-13+, and GM-CSF+ CD4+ T cells from the (A) peritoneal cavity 
and (B) mesenteric lymph nodes after in vitro PMA/ionomycin stimulation. Data are pooled 
from 2 independent experiments. Data are mean ± s.e.m. Significance calculated with an 




Figure 3.9. In vitro-polarized TH2 cells require Bhlhe40 for normal cytokine production. 
Naïve CD4+ T cells from Bhlhe40+/+ and Bhlhe40-/- mice were differentiated in culture into TH2 
cells and restimulated to assess production of GM-CSF, IL-4, IL-5, and IL-13 by ELISA. Data 
are pooled from 3 independent experiments. Data are mean ± s.e.m. Significance calculated 















Figure 3.10. Genetic deletion of IL-10 in Bhlhe40-/- Il10-/- mice does not restore control of H. 
polygyrus rechallenge. (A) Naïve and H. polygyrus-rechallenged Cd4-Cre- Bhlhe40fl/fl and 
Cd4-Cre+ Bhlhe40fl/fl mice were analyzed by flow cytometry for quantitation of the frequency 
of IL-10+ CD4+ T cells after in vitro PMA/ionomycin stimulation of SILP cells. (B) H. 
polygyrus-rechallenged Bhlhe40+/+, Bhlhe40-/-, and Bhlhe40-/- Il10-/- mice were analyzed for 
quantitation of H. polygyrus eggs/gram feces over time. (C) Naïve and H. polygyrus-
rechallenged Bhlhe40+/+, Bhlhe40-/-, and Bhlhe40-/- Il10-/- mice were analyzed for quantitation 
of intestinal granulomas. Data are pooled from 2 independent experiments. Data are mean ± 




Figure 3.11. Combined deficiency in IL-5 and GM-CSF results in impaired control of H. 
polygyrus rechallenge. (A) H. polygyrus-rechallenged Csf2+/+ and Csf2-/- mice were analyzed 
for quantitation of H. polygyrus eggs/gram feces over time. (B) Naïve and H. polygyrus-
rechallenged Csf2+/+ and Csf2-/- mice were analyzed for quantitation of intestinal granulomas.  
(C) Naïve and H. polygyrus-rechallenged Csf2+/+ and Csf2-/- mice were analyzed by flow 
cytometry for quantitation of SILP myeloid cells. (D-F) Naïve and H. polygyrus-rechallenged 
Csf2+/+ and Csf2-/- mice were analyzed by flow cytometry for quantitation of (D) peritoneal 
eosinophils, (E) LPMs, and (F) the frequency of RELMα+ LPMs. (G) Wild type mice were 
rechallenged with H. polygyrus concurrent with control IgG, αGM-CSF, αIL-5, or αGM-CSF 
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plus αIL-5 antibody treatment and were analyzed for quantitation of H. polygyrus eggs/gram 
feces over time. (H) Naïve (open circles) and H. polygyrus-rechallenged mice (filled 
triangles) treated as in (G) were analyzed for quantitation of intestinal granulomas. Data are 




















Figure 3.12. The βC chain is necessary for control of H. polygyrus rechallenge. (A) H. 
polygyrus-rechallenged Csf2rb+/+ and Csf2rb-/- mice were analyzed for quantitation of H. 
polygyrus eggs/gram feces over time. (B) Naïve and H. polygyrus-rechallenged Csf2rb+/+ and 
Csf2rb-/- mice were analyzed for quantitation of intestinal granulomas. (C-F) Naïve and H. 
polygyrus-rechallenged Csf2rb+/+ and Csf2rb-/- mice were analyzed by flow cytometry for 
quantitation of (C) SILP myeloid cells, (D) peritoneal eosinophils, (E) LPMs, and (F) the 
frequency of RELMα+ LPMs. Data are pooled from 2 independent experiments. Data are 





 Chapter 4: Conclusions and Future Directions 
 
4.1 Introduction  
As a result of our work and that of other groups, a remarkable variety of roles for Bhlhe40 within 
the hematopoietic system are now emerging. Bhlhe40 regulates T helper cell cytokine production 
(Martinez-Llordella et al., 2013; Lin et al., 2014; Lin et al., 2016; Yu et al., 2018; Jarjour et al., 
2019b), macrophage proliferation (Jarjour et al., 2019a), and type 2 immunity (Jarjour et al., 
2019a; Jarjour et al., 2019b). Herein, I will expand on these and related points.  
 
4.2 Macrophages  
 While the literature on Bhlhe40’s role in the proliferation of lymphocytes is somewhat 
unclear and affected by redundancy with Bhlhe41 (Martinez-Llordella et al., 2013; Yu et al., 
2018; Kreslavsky et al., 2018), we have established a crucial tissue-specific role for Bhlhe40 in 
the proliferation of peritoneal resident and monocyte-derived macrophages. The finding that 
macrophages have tissue-specific controls on their proliferation, even in an inflammatory 
context, has significant repercussions. Our data suggests that other proliferative macrophages, 
such as tumor-associated or pro-fibrotic populations (Franklin et al., 2016; Minutti et al., 2017; 
Mantovani et al., 2017; Zhu et al., 2017; Loyher et al., 2018), likely possess similar 
transcriptional regulators, which could be therapeutically manipulated. Furthermore, Bhlhe40 
itself may be a promising target as peritoneal macrophages likely contribute to the tumor-
associated macrophage pool in certain cancers, as these populations are known to incorporate 
resident macrophages (Zhu et al., 2017; Loyher et al., 2018). It is of great importance to identify 
these other regulators of macrophage proliferation; however, the case of Bhlhe40 suggests that 
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this may not be simple. Bhlhe40 is not exclusively expressed in LPMs, nor is its expression 
dramatically enhanced during proliferation. The most promising avenue to address this may be 
by focusing on regulators of Maf transcription factors, based on the premise that tissue-specific 
factors share an ability to regulate Mafs. 
As our understanding of the relationship between monocytes and macrophages has 
advanced, it has become less clear why both populations are necessary. The most likely 
explanation is that tissue-resident macrophages are relatively restricted in their ability to respond 
to insults and may be more pro-tolerogenic, while monocytes are able to differentiate into every 
flavor of macrophage imaginable.  Our data strongly supports this idea by showing that 
monocytes retain additional transcriptional plasticity as compared to tissue-resident 
macrophages, which could not acquire Bhlhe40 expression during type 2 immunity. 
Furthermore, our findings suggest that Bhlhe40 itself could be a therapeutic target in 
pathological monocyte-derived macrophages. Intriguingly, peritoneal monocyte-derived 
macrophages had a more profound proliferative defect in the absence of Bhlhe40 than LPMs, 
possibly due to compensation by Bhlhe41 in LPMs. It remains an open question whether double 
deficiency in Bhlhe40 and Bhlhe41 would impair the proliferation of more macrophage subsets, 
especially AMs (which highly express Bhlhe41). 
 
4.3 Helper T cells 
 Our results clearly demonstrate that Bhlhe40 plays a crucial role in controlling TH2 cell 
cytokine production, with marked similarities to its role in other helper T cell subsets. Bhlhe40 
and c-Maf (Gabrysova et al., 2018) are emerging as potential master regulators of helper T cell 
cytokine production. The existence of such factors suggests that different helper T cell subsets 
116 
 
may share further regulation, despite their divergent transcriptional programs enforced by master 
lineage-specifying transcription factors. These findings suggest that T cell differentiation is less a 
series of irrevocable decisions (i.e. a golf ball in a lake) and more a limitation of the possible 
outcomes (i.e. a golf ball in a sand trap). While TH1 and TH2 cells likely are never able to 
exchange identities, they are capable of sharing secondary characteristics (i.e. a TH1-GM and 
TH2-GM). Conceptually, a corollary of this idea would be primary (Tbet, Gata3, RORγt, FoxP3, 
Bcl6) and secondary (Bhlhe40, c-Maf) helper T cell transcription factors. 
Naturally, as in all things biological, there is likely a continuum between primary and 
secondary transcription factors. In light of the marked changes in the helminth-induced 
transcriptional signature in SILP CD4+ T cells lacking Bhlhe40 and the recent study by 
Henriksson et al describing Bhlhe40 as a TH2 regulator, it is of great interest to address whether 
Bhlhe40 also has unique functions in TH2 cells that contribute to the transcriptome of this cell 
type. Furthermore, because of the transcriptional similarities between ILC and helper T cell 
subsets, it is likely that Bhlhe40 also plays an important role in ILCs. If so, it would be 
fascinating to address the relative importance of Bhlhe40-mediated cytokine production in ILCs 
versus helper T cells. 
 
4.4 Type 2 immunity  
 Because of the roles we have described for Bhlhe40 in peritoneal macrophages and TH2 
cells, Bhlhe40 appears to be an important regulator of type 2 immune responses. Cooperative 
roles for a single transcription factor in multiple cell types during type 2 immunity is reminiscent 
of the role of IRF4 in dendritic cells and TH2 cells (Williams et al., 2013; Gao et al., 2013). 
Intriguingly, Bhlhe40 was connected to IRF4 by Henriksson et al, though our transcriptional data 
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did not reveal any significant difference in Irf4 expression between Bhlhe40-sufficient and 
deficient LPMs or TH2 cells. Bhlhe40 is highly expressed in other myeloid cell lineages which 
are important in type 2 immunity, suggesting that Bhlhe40 may be of even greater importance to 
this type of immune response. Furthermore, as type 2 immune responses prominently feature 
feedback loops (Ouyang et al., 2000; von Moltke et al., 2016), many of the indirect effects of 
Bhlhe40 deficiency in T cells remain to be explored, such as the effects on the epithelium 
(including tuft cells) and ILCs. 
Bhlhe40 is highly expressed in a significant fraction of dendritic cells in the lung and 
spleen (Lin et al., 2016; unpublished data), and so it is a distinct possibility that Bhlhe40 could 
regulate Irf4 expression to modulate dendritic cells during type 2 immunity, in light of the role 
for IRF4 described above. As previously mentioned, our original interest in Bhlhe40 was piqued 
by its expression in monocytes in response to GM-CSF. As GM-CSF induces the differentiation 
of monocyte-derived dendritic cells (Briseno et al., 2016), it is possible that Bhlhe40 is important 
in both classical and monocyte-derived dendritic cells, which are potentially important in 
different type 2 models. 
Bhlhe40 is expressed at a remarkably high level in lung, peritoneal, bone marrow, and 
intestinal eosinophils (Lin et al., 2016; unpublished data), suggesting that it also plays a role in 
this cell type. As eosinophils have the potential to secrete a variety of cytokines, including some 
more classically considered to be lymphocyte-derived, it is possible that Bhlhe40 also regulates 




4.5 Common beta chain family cytokines 
While IL-5 and GM-CSF have been studied for decades, these factors have largely been 
interrogated in parallel. IL-5 has been a major focus of research on type 2 immunity, including 
parasitic, atopic, and other diseases, while GM-CSF has emerged as a proinflammatory mediator, 
particularly in TH1 and TH17 cell-driven diseases, such as autoimmunity, bacterial infections, and 
cancer. And yet, among all the known cytokines regulating the immune system, these two are 
uniquely linked as the only cytokines entirely dependent on the βC chain for transducing 
downstream signaling (Dougan et al., 2019). The studies on these two factors present a 
conundrum of how essentially identical signaling can create such disparate effects. Of course, 
part of this is the availability of the relevant alpha chains, which are necessary to bind these 
cytokines. But this idea inevitably leads to the idea of redundancy of GM-CSF and IL-5 if both 
cytokines and both alpha chains are available.  
 We have found that either GM-CSF or IL-5 is sufficient to maintain protective immunity 
to H. polygyrus, but deficiency in both causes severely impaired immunity. This helps to address 
the long-standing confusion over the varying importance of IL-5 in anti-helminth immunity by 
revealing compensatory mechanisms (Maizels and Balic, 2004; Allen and Sutherland, 2014). It is 
now imperative to address whether GM-CSF and IL-5 broadly cooperate in other type 2 diseases, 
especially the various sorts of atopy. For example, trials of αIL-5 therapy in eosinophilic 
eosophagitis led to inconsistent clinical outcomes, and eosinophil levels were only partially 
suppressed by therapy (Roufosse et al., 2018). Would combined blockade of GM-CSF (using 
blocking antibodies already in clinical trials) and IL-5 yield an improved therapeutic modality? 
 While our work has clearly demonstrated that TH2 responses prominently feature GM-
CSF production, thereby rendering this cytokine relevant during type 2 immunity, the question 
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remains of whether IL-5 is also important in a more proinflammatory context. GM-CSF is 
currently being therapeutically targeted in rheumatoid arthritis and multiple sclerosis (Dougan et 
al., 2019). Is it possible that combined blockade of IL-5 would eliminate a compensatory 
mechanism? There are two potential mechanisms by which IL-5 could compensate for GM-CSF 
in inflammatory diseases. One, IL-5 could play an undescribed role in these diseases (likely 
reparative or profibrotic), or two, IL-5 could be induced in the absence of GM-CSF signaling, 
resulting in compensation. While there is little-to-no literature on IL-5 during rheumatoid 
arthritis, it was previously shown that IL-5-deficient mice develop the murine model of multiple 
sclerosis normally (experimental autoimmune encephalomyelitis), suggesting that IL-5 is not 
normally involved in this disease, but not precluding a secondary, compensatory role vis a vis 
GM-CSF (Weir et al., 2003). 
 
4.6 A unifying role for Bhlhe40 
As of yet, the functions of Bhlhe40 appear to be quite distinct between different cell 
types. Bhlhe40 is induced by many different stimuli to play different roles in different cell types. 
One strong possibility is that this simply reflects the typical biology of transcription factors. As 
there are relatively few, they partner with each other in different ways in different cells to 
mediate different functions. However, it remains possible that there may be a unifying logic or 
mechanism behind these seemingly disparate functions. One noteworthy contender is the 
circadian clock. Bhlhe40 has previously been described to regulate circadian rhythms (Honma et 
al., 2001). Is it possible that Bhlhe40 couples cytokine production and proliferation to the time of 
day? In light of the circadian patterns of neutrophils (Adrover et al., 2019), Bhlhe40 might also 
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be relevant to the granulocyte clock, as it is expressed in multiple granulocyte subsets (Lin et al., 
2016). 
 
4.7 Concluding remarks 
At the start of my thesis work, I proposed to unravel the role of Bhlhe40 in the biology of tissue-
resident macrophages in both cellular and molecular detail. We have accomplished this by 
describing a tissue-specific role for Bhlhe40 in regulating the proliferation of peritoneal 
macrophages via repression of c-Maf and MafB, revealing a new paradigm of tissue-specific 
control of resident macrophage proliferation that is active in health and disease. This work was 
recently published in Nature Immunology (DOI 10.1038/s41590-019-0382-5). While we initially 
anticipated an important role for Bhlhe40 in alveolar macrophages, which highly express this 
factor, we found remarkably few differences in gene expression or changes in function in 
homeostasis. We suspect that this is in part due to high expression of Bhlhe41, leading to 
compensation, and the previously described lack of MafB and c-Maf in these cells (Soucie et al., 
2016). It would be of great interest to assess whether Bhlhe40/41-deficient mice have significant 
changes in the behavior of alveolar macrophages. 
 In the course of these studies, I adopted a number of models of type 2 immunity, 
including the murine helminth Heligmosomoides polygyrus. We invested much effort in 
connecting peritoneal macrophages to the control of this infection, but were unable to do so. 
However, we did reveal a marked requirement for Bhlhe40 in T cells to control rechallenge 
infections with this pathogen. We found that Bhlhe40 was critical to the normal transcriptional 
response of small intestine lamina propria CD4+ T cells to helminth infection, including 
expression of Areg, Csf2, Il5, Il13, Nlrp3, and Pparg. In light of the defects in production of the 
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common beta chain family cytokines GM-CSF and IL-5 in the absence of Bhlhe40, we assessed 
whether these cytokines were required for control of infection. Our work and previously 
published data on IL-5 neutralization in this model (Urban et al., 1991) demonstrate that single 
deficiency in either factor has little-to-no effect on protection against H. polygyrus, but loss of 
the common beta chain or double neutralization of both factors results in a profound defect. 
Therefore, our data may explain the inconsistent requirements for IL-5 in various helminth 
infections and suggest that GM-CSF and IL-5 may frequently cooperate in type 2 immunity and 
other diseases, suggesting the therapeutic potential of double blockade of these factors. This 
work has been published as a preprint on bioRxiv (DOI 10.1101/687541) and has been submitted 
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